Document:

Purchase Agreement

 EXHIBIT 4.1 
  

EXECUTION COPY 
  
 The TriZetto Group, Inc. 
  
 $100,000,000 Principal Amount 
  
 2.75% Convertible Senior Notes due 2025 
  
 PURCHASE AGREEMENT 
  
 September 30, 2005 

 PURCHASE AGREEMENT 
  
 September 30, 2005 
  
 UBS Securities LLC 
   on behalf of Initial Purchasers 
 c/o UBS Securities LLC 
 299 Park Avenue 
 New York, New York 10171-0026 
  
 Ladies and Gentlemen: 
  
 The TriZetto Group, Inc, a Delaware corporation (the
“Company”), proposes to issue and sell to the initial purchasers named in Schedule A hereto (the “Initial Purchasers”) $100,000,000 aggregate principal amount of its 2.75% Convertible Senior Notes due 2025
(the “Firm Notes”). In addition, the Company proposes to grant to the Initial Purchasers the option to purchase from the Company up to an additional $15,000,000 aggregate principal amount of the Company’s 2.75% Convertible
Senior Notes due 2025 solely to cover over-allotments (the “Additional Notes”). The Firm Notes and the Additional Notes are hereinafter collectively sometimes referred to as the “Notes.” 
  
 The Notes are to be issued pursuant to an indenture (the
“Indenture”) to be dated as of October 5, 2005, between the Company and Wells Fargo Corporate Trust, as trustee (the “Trustee”). The Notes will be convertible in accordance with their terms and the terms of the
Indenture into shares of the common stock (the “Common Stock”) of the Company, $0.001 par value per share (the “Shares”). 
  
 The Notes and the Shares will be offered without being registered under the Securities Act of 1933, as amended (the “Act”), to
“qualified institutional buyers” in compliance with the exemption from registration provided by Rule 144A under the Act (“Rule 144A”). 
  
 The Initial Purchasers and their direct and indirect transferees will be entitled to the benefits of a Registration Rights
Agreement to be entered into at or prior to the “time of purchase” (as defined herein) between the Company and the Initial Purchasers (the “Registration Rights Agreement”). 
  
 In connection with the sale of the Notes, the Company has prepared a
preliminary offering memorandum (the “Preliminary Memorandum”) and will prepare a final offering memorandum (the “Final Memorandum” and, with the Preliminary Memorandum, each a “Memorandum”)
including or incorporating by reference a description of the terms of the Notes and the Shares, the terms of the offering and a description of the Company. As used herein, the terms “Preliminary Memorandum,” “Final Memorandum”
and “Memorandum” shall in each case include the documents incorporated by reference therein, if any. The terms “supplement,” “amendment” and “amend” as used herein with respect to a
Memorandum shall include the filing of any document, if any, deemed to be incorporated by reference in the Preliminary Memorandum or Final Memorandum that are filed after the date of such Memorandum with the Securities and Exchange Commission (the
“Commission”) pursuant to the Securities Exchange 

 
Act of 1934, as amended, and the rules and regulations thereunder (collectively, the “Exchange Act”). As used in this Agreement,
“business day” shall mean a day on which the Nasdaq National Market (the “NASDAQ”) is open for trading. The terms “herein,” “hereof,” “hereto,” “hereinafter” and similar
terms, as used in this Agreement, shall in each case refer to this Agreement as a whole and not to any particular section, paragraph, sentence or other subdivision of this Agreement. 
  
 The Company and the Initial Purchasers agree as follows: 
  
 1. Sale and Purchase. Upon the basis of the warranties and representations and subject to the other terms and
conditions herein set forth, the Company agrees to sell to the Initial Purchasers, and each of the Initial Purchasers, severally and not jointly, agrees to purchase from the Company, the aggregate principal amount of Firm Notes set forth opposite
the name of the Initial Purchasers in Schedule A hereto, at a purchase price of 97% of the principal amount thereof. 
  
 In addition, the Company hereby grants to the Initial Purchasers the option to purchase, and upon the basis of the representations and warranties and
subject to the other terms and conditions herein set forth, the Initial Purchasers shall have the right to purchase, from the Company, all or a portion of the Additional Notes at a purchase price of 97% of the principal amount thereof, plus accrued
interest, if any, from the “time of purchase” (as hereinafter defined) to the “additional time of purchase” (as hereinafter defined), such accrued interest to be calculated in the same manner and at the same rate at which
interest accrues on the Notes in accordance with their terms and the terms of the Indenture. This option may be exercised by UBS Securities LLC (“UBS”), on behalf of the several Initial Purchasers, at any time and from time to time
on or before the thirtieth day following the date hereof by written notice to the Company. Such notice shall set forth the aggregate principal amount of Additional Notes as to which the option is being exercised and the date and time when the
Additional Notes are to be delivered (any such date and time being herein referred to as an “additional time of purchase”); provided, however, that no additional time of purchase shall be (i) earlier than
(a) the “time of purchase” (as defined below) or (b) the second business day after the date on which the option shall have been exercised, or (ii) later than the tenth business day after the date on which the option shall
have been exercised. The principal amount of Additional Notes to be sold to the Initial Purchasers shall be the principal amount which bears the same proportion to the aggregate principal amount of Additional Notes being purchased as the principal
amount of Firm Notes set forth opposite the name of each Initial Purchaser on Schedule A hereto bears to the aggregate principal amount of Firm Notes. 
  
 2. Payment and Delivery. Payment of the purchase price for the Firm Notes shall be made to the Company by Federal Funds wire transfer funds,
against delivery of the Firm Notes to you, at the offices of Willkie Farr & Gallagher LLP in New York, New York, or at such other place as may be agreed upon by the parties hereto, for the respective accounts of the Initial Purchasers. Such
payment and delivery shall be made at 10:00 A.M., New York City time, on October 5, 2005 (unless another time shall be agreed to by you and the Company). The time at which such payment and delivery are actually made is herein sometimes called
the “time of purchase.” 

 Payment of the purchase price for the Additional Notes shall be made at the additional time of purchase
in the same manner and at the same office and time of day as the payment for the Firm Notes. 
  
 Certificates for the Notes shall be in definitive form or global form, as specified by you, and registered in the names and in such denominations as you shall request in writing not later than one full business day
prior to the time of purchase or the additional time of purchase, as the case may be. For the purpose of expediting the checking of the certificates for the Notes by you, the Company agrees to make such certificates available to you for such purpose
at least one full business day preceding the time of purchase or the additional time of purchase, as the case may be. 
  
 Deliveries of the documents described in Section 7 hereof with respect to the purchase of the Notes shall be made at the offices of Willkie
Farr & Gallagher LLP at 787 Seventh Avenue, New York, New York 10019 at 9:00 A.M., New York City time, on the date of the closing of the purchase of the Firm Notes or the Additional Notes, as the case may be. 
  
 3. Representations and Warranties of the Company. The Company
represents and warrants to and agrees with the Initial Purchasers that: 
  
 (a) the Preliminary Memorandum, as of its date and as of the date of any amendment or supplement thereto did not contain an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; the Final Memorandum, as of its date did not, as of the date hereof does not, and, as of the time of purchase or any
additional time of purchase, as of any time at which any sales with respect to which the Final Memorandum is delivered and as it may be further amended or supplemented, will not, contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that the Company makes no warranty or representation
with respect to any statement contained in either Memorandum based upon, and in conformity with, information concerning the Initial Purchasers and furnished in writing by or on behalf of the Initial Purchasers to the Company expressly for use in
either Memorandum; the Company has not, prior to the execution of this Agreement, distributed any “prospectus” (within the meaning of the Act) or offering material in connection with the offering or sale of the Notes other than the then
most recent Preliminary Memorandum and will not, at any time on or after the execution of this Agreement, distribute any “prospectus” (within the meaning of the Act) or offering material in connection with the offering or sale of the Notes
other than the then most recent Final Memorandum; 
  
 (b) each document (each, an “Incorporated Document”), if any, filed or to be filed pursuant to the Exchange Act and incorporated by reference in either Memorandum complied or will comply when so filed in all material
respects with the Exchange Act and 

 
the applicable rules and regulations of the Commission thereunder and did not contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; 
  
 (c) the Company satisfies all conditions for the use of a registration statement on Form S-3 under the Act, including without limitation,
(A) the registrant requirements of General Instruction I.A of Form S-3 under the Act and the transaction requirements of General Instructions I.B.1 of Form S-3 under the Act and (B) to register the Notes, and the Shares issuable upon
conversion of the Notes, for resale in the manner contemplated by the Final Memorandum and the Registration Rights Agreement; 
  
 (d) as of the date of this Agreement, the Company has an authorized and outstanding capitalization as set forth in the section of the
Final Memorandum entitled “Capitalization”, and, as of the time of purchase and any additional time of purchase, as the case may be, the Company shall have an authorized and outstanding capitalization as set forth in the section of the
Final Memorandum entitled “Capitalization” (subject to the issuance of shares of Common Stock upon exercise of stock options and warrants disclosed as outstanding in the Final Memorandum and the grant of options and the issuance of stock
under existing plans as described in the Final Memorandum); all of the issued and outstanding shares of capital stock, including the outstanding Common Stock, of the Company have been duly authorized and validly issued and are fully paid and
non-assessable, have been issued in compliance with all federal and state securities laws and were not issued in violation of any preemptive right, resale right, right of first refusal or similar right; and no further approval or authority of the
stockholders or the Board of Directors of the Company are required for the issuance and sale of the Notes and the Shares issuable upon conversion of the Notes; 
  

(e) the Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of
Delaware, with full corporate power and authority to own, lease and operate its properties and conduct its business as described in the Final Memorandum, to execute and deliver this Agreement, the Indenture, the Registration Rights Agreement and the
Notes and to issue, sell and deliver the Notes and the Shares issuable upon conversion of the Notes as contemplated by this Agreement, the Indenture, the Registration Rights Agreement and the Notes; 
  
 (f) the Company is duly qualified to do business as a
foreign corporation and is in good standing in each jurisdiction where the ownership or leasing of its properties or the conduct of its business requires such qualification, except where the failure to be so qualified and in good standing would not,
individually or in the aggregate, either (i) have a material adverse effect on the business, properties, financial condition, results of operations or prospects of the Company and the Subsidiaries (as hereinafter defined) taken as a whole,
(ii) prevent or materially interfere with consummation of the transactions contemplated hereby (including, without limitation, the issuance of the Notes and the Shares) or (iii) result in the delisting of shares of Common Stock from the
NASDAQ (the occurrence of any such effect or any such prevention or interference or any such result described in the foregoing clauses (i), (ii) and (iii) being herein referred to as a “Material Adverse Effect”);

 (g) the Company has no subsidiaries (as defined under the Act) other than Creative
Business Solutions, Inc., Finserv Health Care Systems, Inc., Healthcare Media Enterprises, Inc., HealthWeb, Inc., Infotrust Company, Margolis Health Enterprises, Inc., Novalis Corporation, Digital Insurance Systems Corporation, Health Networks of
America, Inc., Novalis Development Corporation, Novalis Development & Licensing Corporation, Novalis Services Corporation, Options Services Group, Inc., Winthrop Financial Group, Inc., Trizetto Application Services, Inc. and Diogenes, Inc.
(collectively, the “Subsidiaries”); the Company owns all of the issued and outstanding capital stock of each of the Subsidiaries; other than the capital stock of the Subsidiaries, the Company does not own, directly or indirectly,
any shares of stock or any other equity or long-term debt securities of any corporation or have any equity interest in any firm, partnership, joint venture, association or other entity; complete and correct copies of the certificates of
incorporation and the bylaws of the Company and all amendments thereto have been delivered to you, and, except as set forth in the Final Memorandum, no changes therein will be made on or after the date hereof or on or before the time of purchase or,
if later, any additional time of purchase; each Subsidiary has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction of its incorporation, with full corporate power and authority to own,
lease and operate its properties and to conduct its business as described in the Final Memorandum; each Subsidiary is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction where the ownership or leasing
of its properties or the conduct of its business requires such qualification, except where the failure to be so qualified and in good standing would not, individually or in the aggregate, have a Material Adverse Effect; each Subsidiary is in
compliance in all respects with the laws, orders, rules, regulations and directives issued or administered by such jurisdictions, except where the failure to be in compliance would not, individually or in the aggregate, have a Material Adverse
Effect; all of the outstanding shares of capital stock of each of the Subsidiaries have been duly authorized and validly issued, are fully paid and non-assessable, have been issued in compliance with all applicable securities laws, have been issued
in compliance with all federal and state securities laws, were not issued in violation of any preemptive right, resale right, right of first refusal or similar right and are owned by the Company subject to no security interest, other encumbrance or
adverse claims other than security interests, other encumbrances and adverse claims described in the Final Memorandum; and no options, warrants or other rights to purchase, agreements or other obligations to issue or other rights to convert any
obligation into shares of capital stock or ownership interests in the Subsidiaries are outstanding; and the Company has no “significant subsidiary,” as that term is defined in Rule 1-02(w) of Regulation S-X under the Act. 
  
 (h) the capital stock of the Company, including the Shares,
conforms in all material respects to the description thereof contained or incorporated by reference in the Final Memorandum; 

 (i) this Agreement has been duly authorized, executed and delivered by the Company;

  
 (j) the Indenture has been duly authorized by
the Company and, when executed and delivered by the Company and the Trustee, will be a legal, valid and binding agreement of the Company, enforceable in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and general principles of equity; 
  
 (k) the Registration Rights Agreement has been duly authorized by the Company and, when executed and delivered by the Company and the
Initial Purchasers, will be a legal, valid and binding agreement of the Company, enforceable in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws
affecting creditors’ rights generally and general principles of equity; 
  
 (l) the Notes have been duly authorized by the Company and, when executed and delivered by the Company and duly authenticated in accordance with the terms of the Indenture and delivered to and paid for by the Initial
Purchasers in accordance with the terms hereof, will constitute legal, valid and binding obligations of the Company, enforceable in accordance with their terms, except as the enforceability thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors’ rights generally and general principles of equity, and will be entitled to the benefits of the Indenture and the Registration Rights Agreement; the Shares issuable upon conversion
of the Notes have been duly authorized and validly reserved for issuance upon conversion of the Notes, and, upon conversion of the Notes in accordance with their terms and the terms of the Indenture, will be issued free of statutory and contractual
preemptive rights, resale rights, rights of first refusal and similar rights and free of any voting restrictions, and are sufficient in number to meet the current conversion requirements (assuming all conditions to such conversion have been
satisfied) based on the Conversion Rate (as defined in the Indenture) in effect as of the time of purchase and as of any additional time of purchase; such Shares, when so issued upon such conversion in accordance with the terms of the Notes and of
the Indenture, will be duly and validly issued and fully paid and nonassessable; and the certificates for such Shares will be in due and proper form, and the holders of the Shares will not be subject to personal liability by reason of being such
holders; 
  
 (m) the terms of the Notes, the
Registration Rights Agreement, the Indenture and the capital stock of the Company, including the Shares, conform in all material respects to the descriptions thereof contained in the Final Memorandum; 
  
 (n) when the Notes are issued pursuant to this Agreement,
the Notes will not be of the same class (within the meaning of Rule 144A) as securities that are listed on a national securities exchange registered pursuant to Section 6 of the Exchange Act or quoted in a U.S. automated inter-dealer quotation
system; 

 (o) neither the Company nor any “affiliate” (as defined in Rule 501(b) of
Regulation D under the Act, an “Affiliate”) of the Company has directly, or through any agent, (i) sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any “security” (as defined in
the Act), which sale, offer, solicitation or negotiation is or will be integrated with the offer or sale of the Notes in a manner that would require the registration under the Act of the Notes or (ii) offered, solicited offers to buy or sold
the Notes by any form of “general solicitation” or “general advertising” (as those terms are used in Regulation D under the Act) or in any manner involving a public offering within the meaning of Section 4(2) of the Act;

  
 (p) it is not necessary in connection with
the offer, sale and delivery of the Notes to the Initial Purchasers pursuant to this Agreement to register the Notes or the Shares under the Act or to qualify the Indenture under the Trust Indenture Act of 1939, as amended (the “Trust
Indenture Act”); assuming the Initial Purchasers offer and sell the Notes only to persons whom they, or their agents, reasonably believe are “qualified institutional buyers” (“QIBs”) within the meaning of Rule
144A, it is not necessary in connection with the offer, sale and delivery of the Notes by the Initial Purchasers to such persons in the manner contemplated by the Final Memorandum to register the Notes or the Shares under the Act or to qualify the
Indenture under the Trust Indenture Act; it is not necessary to register under the Act any Shares issued upon conversion of the Notes in accordance with their terms and the terms of the Indenture; 
  
 (q) neither the Company nor any of the Subsidiaries is in
breach or violation of or in default under (nor has any event occurred which with notice, lapse of time or both would result in any breach or violation of, constitute a default under or give the holder of any indebtedness (or a person acting on such
holder’s behalf) the right to require the repurchase, redemption or repayment of all or a part of such indebtedness under) (A) its respective charter or bylaws, or (B) any indenture, mortgage, deed of trust, bank loan or credit
agreement or other evidence of indebtedness, or any license, lease, contract or other agreement or instrument to which the Company or any of the Subsidiaries is a party or by which any of them or any of their respective properties may be bound or
affected, except for breaches, violations or defaults that would not, individually or in the aggregate, have a Material Adverse Effect, or (C) any federal, state, local or foreign law, regulation or rule, except for breaches, violations or
defaults that would not, individually or in the aggregate, have a Material Adverse Effect, or (D) any rule or regulation of any self-regulatory organization or other non-governmental regulatory authority (including, without limitation, the
rules and regulations of NASDAQ, except for breaches, violations or defaults that would not, individually or in the aggregate, have a Material Adverse Effect, or (E) any decree, judgment or order applicable to the Company or any of the
Subsidiaries or any of their respective properties; and the execution, delivery and performance of this Agreement, the Indenture, the Registration Rights Agreement and the Notes and the consummation of the transactions contemplated hereby and
thereby, including the issuance of the Notes and the issuance of the Shares issuable upon conversion of the Notes, will not conflict with, result in any breach or violation of or constitute a default under (nor constitute any event which with

 
notice, lapse of time or both would result in any breach or violation of or constitute a default under or give the holder of any indebtedness (or a person
acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a part of such indebtedness under) (or result in the creation or imposition of a lien, charge or encumbrance on any property or assets of the
Company or any Subsidiary pursuant to) (I) the charter or bylaws of the Company or any of the Subsidiaries, or (II) any indenture, mortgage, deed of trust, bank loan or credit agreement or other evidence of indebtedness, or any license, lease,
contract or other agreement or instrument to which the Company or any of the Subsidiaries is a party or by which any of them or any of their respective properties may be bound or affected, except for conflicts, breaches, violations or defaults that
would not, individually or in the aggregate, have a Material Adverse Effect, or (III) any federal, state, local or foreign law, regulation or rule, or (IV) any rule or regulation of any self-regulatory organization or other non-governmental
regulatory authority (including, without limitation, the rules and regulations of the NASDAQ, or (V) any decree, judgment or order applicable to the Company or any of the Subsidiaries or any of their respective properties; 
  
 (r) no approval, authorization, consent or order of or
filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other non-governmental regulatory authority (including, without limitation,
the NASDAQ), or approval of the stockholders of the Company, is required in connection with the issuance and sale by the Company of the Notes or the issuance of Shares upon conversion of the Notes or the consummation of the transactions as
contemplated hereby and by the Indenture, the Registration Rights Agreement and the Notes, other than (i) as may be required under the securities or blue sky laws of the various jurisdictions in which the Notes and the Shares are being offered
by the Initial Purchasers and (ii) as may be required by federal and state securities laws with respect to the Company’s obligations under the Registration Rights Agreement; 
  
 (s) except as expressly set forth in the Final Memorandum, (i) no person has the right, contractual or
otherwise, to cause the Company to issue or sell to it any shares of Common Stock or shares of any other capital stock or other equity interests of the Company, (ii) no person has any preemptive rights, resale rights, rights of first refusal or
other rights to purchase any shares of Common Stock or shares of any other capital stock of or other equity interests in the Company and (iii) no person has the right to act as an initial purchaser or as a financial advisor to the Company in
connection with the offer and sale of the Notes, in the case of each of the foregoing clauses (i), (ii) and (iii), whether as a result of the sale of the Notes as contemplated hereby or otherwise; except for registration rights pursuant to
which the Company has filed one or more registration statements with the Commission that are currently effective and except for any other registration rights disclosed in the Final Memorandum, no person has the right, contractual or otherwise, to
cause the Company to register under the Act any shares of Common Stock or shares of any other capital stock of or other equity interests in the Company, or to include any such shares or interests in any registration statement to be filed with the
Commission pursuant to the Registration Rights Agreement, whether as a result of the sale of the Notes as contemplated hereby or otherwise; 

 (t) each of the Company and the Subsidiaries has all necessary licenses, authorizations,
consents and approvals and has made all necessary filings required under any federal, state, local or foreign law, regulation or rule, and has obtained all necessary licenses, authorizations, consents and approvals from other persons, in order to
conduct its respective business, except where failure to have such licenses, authorizations, consents or approvals, or to make such filings, would not, individually or in the aggregate, have a Material Adverse Effect; neither the Company nor any of
the Subsidiaries is in violation of, or in default under, or has received notice of any proceedings relating to revocation or modification of, any such license, authorization, consent or approval or any federal, state, local or foreign law,
regulation or rule or any decree, order or judgment applicable to the Company or any of the Subsidiaries, except where such violation, default, revocation or modification would not, individually or in the aggregate, have a Material Adverse Effect;

  
 (u) all legal or governmental proceedings,
affiliate transactions, off-balance sheet transactions (including, without limitation, transactions related to, and the existence of, “variable interest entities” within the meaning of Financial Accounting Standards Board Interpretation
No. 46), contracts, licenses, agreements, properties, leases or documents of a character required to be described in the Final Memorandum (assuming the Final Memorandum were a prospectus included in a registration statement under the Act) or
any Incorporated Document or to be filed as an exhibit to any Incorporated Document have been so described or filed as required; 
  
 (v) there are no actions, suits, claims, investigations or proceedings pending or, to the best of the Company’s knowledge, threatened
or contemplated to which the Company or any of the Subsidiaries or, to the best of the Company’s knowledge, any of their respective directors or officers is or would be a party or of which any of their respective properties is or would be
subject at law or in equity, before or by any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or before or by any self-regulatory organization or other non-governmental regulatory authority
(including, without limitation, the rules and regulations of the NASDAQ), except any such action, suit, claim, investigation or proceeding which would not result in a judgment, decree or order having, individually or in the aggregate, a Material
Adverse Effect; 
  
 (w) Ernst & Young
LLP, whose report on the consolidated financial statements of the Company and the Subsidiaries is incorporated by reference in the Final Memorandum, are independent registered public accountants as required by the Act and by the rules of the Public
Company Accounting Oversight Board; 
  
 (x) the
financial statements included or incorporated by reference in the Final Memorandum, together with the related notes and schedules, present fairly the consolidated financial position of the Company and the Subsidiaries in all material respects as of
the dates indicated and the consolidated results of operations and cash 

 
flows of the Company and the Subsidiaries for the periods specified and have been prepared in compliance with the requirements of the Act and Exchange Act
and in conformity with generally accepted accounting principles applied on a consistent basis during the periods involved; all pro forma financial statements or data included or incorporated by reference in the Final Memorandum comply with the
requirements of Regulation S-X of the Act, including, without limitation, Article 11 thereof, and the assumptions used in the preparation of such pro forma financial statements and data are reasonable, the pro forma adjustments used therein are
appropriate to give effect to the transactions or circumstances described therein and the pro forma adjustments have been properly applied to the historical amounts in the compilation of those statements and data; the other financial and statistical
data set forth or incorporated by reference in the Final Memorandum are accurately and fairly presented and prepared on a basis consistent with the financial statements and books and records of the Company; there are no financial statements
(historical or pro forma) that are required to be included or incorporated by reference in the Final Memorandum (assuming the Final Memorandum were a prospectus included in a registration statement under the Act) or any Incorporated Document
(including, without limitation, as required by Rules 3-12 or 3-05 or Article 11 of Regulation S-X under the Act) that are not included or incorporated by reference as required; the Company and the Subsidiaries do not have any material liabilities or
obligations, direct or contingent (including any off-balance sheet obligations), not disclosed in the Final Memorandum; except as disclosed in the Final Memorandum, neither the Company nor any Subsidiary is, together with its “related
parties,” the “primary beneficiary” of any “variable interest entity” (as such terms are used in Financial Accounting Standards Board Interpretation No. 46); and all disclosures contained in the Final Memorandum,
including the documents incorporated by reference therein, regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission) comply with Regulation G of the Exchange Act and Item 10 of
Regulation S-K under the Act, to the extent applicable, assuming the Final Memorandum were a prospectus included in a registration statement under the Act; 
  
 (y) subsequent to the time of execution of this Agreement or, if earlier, the respective dates as of which information is given in the
Final Memorandum, there has not been (i) any material adverse change, or any development involving a prospective material adverse change, in the business, properties, management, financial condition or results of operations of the Company and
the Subsidiaries taken as a whole, (ii) any transaction which is material to the Company and the Subsidiaries taken as a whole, (iii) any obligation, direct or contingent (including any off-balance sheet obligations), incurred by the
Company or any Subsidiary, which is material to the Company and the Subsidiaries taken as a whole, (iv) any change in the capital stock or outstanding indebtedness of the Company or any Subsidiaries or (v) any dividend or distribution of
any kind declared, paid or made on the capital stock of the Company or any Subsidiary; 
  
 (z) the Company has obtained for the benefit of the Initial Purchasers the agreement (a “Lock-Up Agreement”), in the form
set forth as Exhibit A hereto, of each of its directors and “officers” (within the meaning of Rule 16a-1(f) under the Act) and certain stockholders, the parties to execute such Lock-Up Agreements are named in Exhibit A-1
hereto; 

 (aa) neither the Company nor any Subsidiary is and, after giving effect to the offering
and sale of the Notes and the application of the proceeds thereof as described in the Final Memorandum, neither of them will be an “investment company” or an entity “controlled” by an “investment company,” as such terms
are defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”); 
  
 (bb) the Company, and each of the Subsidiaries, has good and marketable title to all property (real and personal) described the Final
Memorandum or any Incorporated Document as being owned by each of them, free and clear of all liens, claims, security interests or other encumbrances, except as otherwise described in the Final Memorandum or any Incorporated Document and except as
would not, individually or in the aggregate, materially effect the value of the property to the Company and its Subsidiaries; all the property described in the Final Memorandum or any Incorporated Document as being held under lease by the Company or
a Subsidiary is held thereby under valid, subsisting and enforceable leases; 
  
 (cc) the Company and the Subsidiaries own, all right, title and interest in and to, or have obtained valid and enforceable licenses for, or other rights to use, the inventions (whether or not patentable), patent
applications, patents, trademarks (both registered and unregistered), service marks, tradenames, or other indications of origin, service names, copyrights, trade secrets, computer software, database rights, Internet websites and domain names and
other proprietary information described in the Final Memorandum as being owned or licensed by them or which are necessary for the conduct of their respective businesses as currently conducted (including the commercialization of products or services
described in the Final Memorandum to the extent developed or being developed), except where the failure to own, license or have such rights would not, individually or in the aggregate, have a Material Adverse Effect (collectively,
“Intellectual Property”); (i) there are no third parties who have or, to the Company’s knowledge, will be able to establish rights to any Intellectual Property, except for, and to the extent of, the ownership rights of the
third parties which have licensed Intellectual Property which the Final Memorandum discloses is licensed to the Company; (ii) to the Company’s knowledge, there is no infringement by third parties of any Intellectual Property;
(iii) there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others challenging the Company’s rights in or to any Intellectual Property, and the Company is unaware of any facts which could
form a reasonable basis for any such action, suit, proceeding or claim; (iv) there is no pending or to the Company’s knowledge, threatened action, suit, proceeding or claim by others challenging the validity, enforceability or scope of any
Intellectual Property, and the Company is unaware of any facts which could form a reasonable basis for any such action, suit, proceeding or claim; (v) except as described in the Final Memorandum, there is no pending or to the Company’s
knowledge, threatened action, suit, proceeding or claim by others that the Company or any Subsidiary infringes or otherwise violates, or would, upon the use or commercialization of the products or services described in the Final Memorandum as under
development, infringe or violate, any patent, trademark, 

 
tradename, service name, copyright, trade secret or other proprietary rights of others, and the Company is unaware of any facts which could form a reasonable
basis for any such action, suit, proceeding or claim; (vi) the Company and the Subsidiaries have complied with the terms of any agreement pursuant to which Intellectual Property has been licensed to the Company or any Subsidiary, and all such
agreements are in full force and effect, except for failures to comply that would not, individually or in the aggregate, have a Material Adverse Effect; (vii) to the Company’s knowledge, the manufacture, use or sale of any product or
service, or, upon the commercialization thereof, any product or service described in the Final Memorandum or any Incorporated Document as under development by the Company or any Subsidiary would not be held to infringe any claims in any patents of
third parties; (viii) to the Company’s knowledge, there is no patent or patent application that contains claims that interfere with the issued or pending claims of any of the Intellectual Property or that challenges the validity,
enforceability or scope of any of the Intellectual Property; and (ix) to the Company’s knowledge, there is no prior art that may render any patent application owned by the Company or any Subsidiary of the Intellectual Property unpatentable
that has not been disclosed to the U.S. Patent and Trademark Office; 
  
 (dd) Neither the Company nor any of the Subsidiaries has (i) incorporated open source materials into, or combined open source materials with, the Intellectual Property; (ii) distributed open source materials
in conjunction with any of the Intellectual Property; or (iii) used open source materials that, as a result of such incorporation, combination, distribution or use, would cause licensees of such Intellectual Property to be entitled to:
(A) copy, sell or give away the Intellectual Property or modifications or derivative works thereof without compensation to the licensor; (B) available access to the source code of the Intellectual Property; or (C) modify and create
derivative works of the Intellectual Property software; 
  
 (ee) neither the Company nor any of the Subsidiaries is engaged in any unfair labor practice; except for matters which would not, individually or in the aggregate, have a Material Adverse Effect, (i) there is
(A) no unfair labor practice complaint pending or, to the Company’s knowledge, threatened against the Company or any of the Subsidiaries before the National Labor Relations Board, and no grievance or arbitration proceeding arising out of
or under collective bargaining agreements is pending or threatened, (B) no strike, labor dispute, slowdown or stoppage pending or, to the Company’s knowledge, threatened against the Company or any of the Subsidiaries and (C) no union
representation dispute currently existing concerning the employees of the Company or any of the Subsidiaries, and (ii) to the Company’s knowledge, (A) no union organizing activities are currently taking place concerning the employees
of the Company or any of the Subsidiaries and (B) there has been no violation of any federal, state, local or foreign law relating to discrimination in the hiring, promotion or pay of employees, any applicable wage or hour laws or any provision
of the Employee Retirement Income Security Act of 1974 (“ERISA”) or the rules and regulations promulgated thereunder concerning the employees of the Company or any of the Subsidiaries; 
  
 (ff) the Company and the Subsidiaries and their properties,
assets and 

 
operations each is in compliance with, and holds all permits, authorizations and approvals required under, Environmental Laws (as defined below), except to
the extent that failure to so comply or to hold such permits, authorizations or approvals would not, individually or in the aggregate, have a Material Adverse Effect; to the Company’s knowledge, there are no past, present or, reasonably
anticipated future events, conditions, circumstances, activities, practices, actions, omissions or plans that could reasonably be expected to give rise to any material costs or liabilities to the Company or any Subsidiary under, or to interfere with
or prevent compliance by the Company or any Subsidiary with, Environmental Laws; except as would not, individually or in the aggregate, have a Material Adverse Effect, neither the Company nor any of the Subsidiaries (i) is the subject of any
investigation, (ii) has received any notice or claim, (iii) is a party to or affected by any pending or, to the best of the Company’s knowledge, threatened action, suit or proceeding, (iv) is bound by any judgment, decree or
order or (v) has entered into any agreement, in each case relating to any alleged violation of any Environmental Law or any actual or alleged release or threatened release or cleanup at any location of any Hazardous Materials (as defined below)
(as used herein, “Environmental Law” means any federal, state, local or foreign law, statute, ordinance, rule, regulation, order, decree, judgment, injunction, permit, license, authorization or other binding requirement, or common
law, relating to health, safety or the protection, cleanup or restoration of the environment or natural resources, including those relating to the distribution, processing, generation, treatment, storage, disposal, transportation, other handling or
release or threatened release of Hazardous Materials, and “Hazardous Materials” means any material (including, without limitation, pollutants, contaminants, hazardous or toxic substances or wastes) that is regulated by or may give
rise to liability under any Environmental Law); 
  
 (gg) in the ordinary course of its business, the Company, and each of the Subsidiaries, conducts, to the extent reasonably necessary, a periodic review of the effect of the Environmental Laws on its business, operations and properties, in
the course of which it identifies and evaluates associated costs and liabilities (including, without limitation, any capital or operating expenditures required for cleanup, closure of properties or compliance with the Environmental Laws or any
permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties); 
  
 (hh) all tax returns required to be filed by the Company or any of the Subsidiaries have been timely filed, and all taxes and other
assessments of a similar nature (whether imposed directly or through withholding) including any interest, additions to tax or penalties applicable thereto due or claimed to be due from such entities have been timely paid, other than those being
contested in good faith and for which adequate reserves have been provided; 
  
 (ii) the Company, and each of the Subsidiaries, maintains insurance covering its properties, operations, personnel and businesses as the Company reasonably deems adequate; such insurance insures against such losses
and risks to an extent which is adequate in accordance with customary industry practice to protect the Company and the 

 
Subsidiaries and their businesses; all such insurance is fully in force on the date hereof and will be fully in force at the time of purchase and any
additional time of purchase; neither the Company nor any Subsidiary has reason to believe that it will not be able to renew any such insurance as and when such insurance expires; 
  
 (jj) neither the Company nor any of the Subsidiaries has sustained since the date of the last audited
financial statements incorporated by reference in the Final Memorandum any loss or interference with its respective business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or
governmental action, order or decree; 
  
 (kk)
neither the Company nor any Subsidiary has sent or received any communication regarding termination of, or intent not to renew, any of the contracts or agreements described in the Final Memorandum or any Incorporated Document, or filed as an exhibit
to any Incorporated Document, and no such termination or non-renewal has been threatened by the Company or any Subsidiary or, to the Company’s knowledge, any other party to any such contract or agreement; 
  
 (ll) the Company, and each of the Subsidiaries, maintains a
system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences; 
  
 (mm) the Company has established and maintains and evaluates
“disclosure controls and procedures” (as such term is defined in Rule 13a-15 and 15d-15 under the Exchange Act) and “internal control over financial reporting” (as such term is defined in Rule 13a-15 and 15d-15 under the Exchange
Act); such disclosure controls and procedures are designed to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to the Company’s Chief Executive Officer and its Chief Financial
Officer by others within those entities, and such disclosure controls and procedures are effective to perform the functions for which they were established; the Company’s auditors and the Audit Committee of the Board of Directors of the Company
have been advised of: (i) any significant deficiencies in the design or operation of internal controls which could adversely affect the Company’s ability to record, process, summarize, and report financial data; and (ii) any fraud,
whether or not material, that involves management or other employees who have a role in the Company’s internal controls; any material weaknesses in internal controls have been identified for the Company’s auditors; since the date of the
most recent evaluation of such disclosure controls and procedures, there have been no significant changes in internal controls or in other factors that could significantly affect internal controls, including any corrective actions with regard to
significant deficiencies and material 

 
weaknesses; the principal executive officers (or their equivalents) and principal financial officers (or their equivalents) of the Company have made all
certifications required by the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) and any related rules and regulations promulgated by the Commission, and the statements contained in any such certification are complete and
correct; the Company, the Subsidiaries and the Company’s directors and officers are each in compliance in all material respects with all applicable effective provisions of the Sarbanes-Oxley Act and the rules and regulations of the Commission
and the NASDAQ promulgated thereunder; 
  
 (nn)
the Company has provided you true, correct and complete copies of all documentation pertaining to any extension of credit in the form of a personal loan made, directly or indirectly, by the Company or any Subsidiary to any director or executive
officer of the Company, or to any family member or affiliate of any director or executive officer of the Company; and on or after July 30, 2002, the Company has not, directly or indirectly, including through any Subsidiary: (i) extended
credit, arranged to extend credit, or renewed any extension of credit, in the form of a personal loan, to or for any director or executive officer of the Company, or to or for any family member or affiliate of any director or executive officer of
the Company; or (ii) made any material modification, including any renewal thereof, to any term of any personal loan to any director or executive officer of the Company, or any family member or affiliate of any director or executive officer,
which loan was outstanding on July 30, 2002; 
  
 (oo) each “forward-looking statement” (within the meaning of Section 27A of the Act or Section 21E of the Exchange Act) contained in either Memorandum has been made or reaffirmed with a reasonable basis and has been
disclosed in good faith; 
  
 (pp) all statistical
or market-related data included in the Final Memorandum or any Incorporated Document are based on or derived from sources that the Company believes to be reliable and accurate, and the Company has obtained the written consent to the use of such data
from such sources to the extent required; 
  
 (qq) neither the Company nor any of the Subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any of the Subsidiaries is aware of or has taken any action, directly or
indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “Foreign Corrupt Practices Act”), including, without limitation,
making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of
the giving of anything of value to any “foreign official” (as such term is defined in the Foreign Corrupt Practices Act) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of
the Foreign Corrupt Practices Act; and the Company, the Subsidiaries and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance in all material respects with the Foreign Corrupt Practices Act and have
instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith; 

 (rr) the operations of the Company and the Subsidiaries are and have been conducted at
all times in compliance in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the
rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”); and no action, suit or proceeding
by or before any court or governmental agency, authority or body or any arbitrator or non-governmental authority involving the Company or any of the Subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the
Company, threatened; 
  
 (ss) neither the Company
nor any of the Subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any of the Subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture
partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC; 
  
 (tt) no Subsidiary is currently prohibited, directly or indirectly, from paying any dividends to the Company, from making any other
distribution on such Subsidiary’s capital stock, from repaying to the Company any loans or advances to such Subsidiary from the Company or from transferring any of such Subsidiary’s property or assets to the Company or any other Subsidiary
of the Company, except as described in the Final Memorandum; 
  
 (uu) immediately after the issuance and sale of the Notes as contemplated hereby, no shares of preferred stock of the Company shall be issued or outstanding; and the issuance and sale of the Notes as contemplated
hereby will not cause any holder of any shares of capital stock, securities convertible into or exchangeable or exercisable for capital stock or options, warrants or other rights to purchase capital stock or any other securities of the Company to
have any right to acquire any shares of preferred stock of the Company; 
  
 (vv) the Company is in compliance with the Marketplace Rules of the NASDAQ, including, without limitation, the requirements for continued designation of the Common Stock as a Nasdaq National Market security, and there
are no actions, suits or proceedings pending or, to the Company’s knowledge, threatened or contemplated, and the Company has not received any notice from the NASDAQ, regarding the revocation of such listing or otherwise regarding the delisting
of shares of Common Stock from the NASDAQ, except as would not, individually or in the aggregate, have an Material Adverse Effect; 

 (ww) if the initial purchasers will sell to foreign persons though a foreign affiliate or
foreign office of the initial purchasers, then either (1) insert this rep “the Company is not, and has not been, a “United States real property holding corporation” within the meaning of Section 897(c)(2) of the
Internal Revenue Code of 1986 during the applicable period specified in Section 897(c)(1)(A)(ii) of the Internal Revenue Code of 1986; 
  
 (xx) the Company has obtained the written consent of Wells Fargo Foothill, Inc., to the execution, delivery and performance of the
Indenture, the Registration Rights Agreement and the Notes and the consummation of the transactions contemplated thereby, including the issuance of the Notes as described in the Final Memorandum; 
  
 (yy) except pursuant to this Agreement, neither the Company
nor any of the Subsidiaries has incurred any liability for any finder’s or broker’s fee or agent’s commission in connection with the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby
or by the Final Memorandum; 
  
 (zz) neither the
Company nor any of the Subsidiaries nor, to the Company’s knowledge, any of their respective directors, officers, affiliates or controlling persons has taken, directly or indirectly, any action designed, or which has constituted or might
reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Notes or the Shares issuable upon conversion of
the Notes. 
  
 In addition, any certificate signed by any officer
of the Company or any of the Subsidiaries and delivered to the Initial Purchasers or counsel for the Initial Purchasers in connection with the offering of the Notes shall be deemed to be a representation and warranty by the Company or Subsidiary, as
the case may be, as to matters covered thereby, to the Initial Purchasers. 
  
 4. Representations and Warranties of the Initial Purchasers. The Initial Purchasers propose to offer the Notes for sale upon the terms and conditions set forth in this Agreement and the Final Memorandum, and
each Initial Purchaser, severally and not jointly, hereby represents and warrants to and agrees with the Company that: 
  
 (a) it will offer and sell the Notes only to persons whom they, or their agents, reasonably believe are QIBs within the meaning of Rule
144A; 
  
 (b) it is a QIB within the meaning of
Rule 144A; and 
  
 (c) it has not engaged and
will not engage in any form of general solicitation or general advertising (as those terms are defined under Regulation D under the Securities Act). 
  
 5. Certain Covenants of the Company. The Company hereby agrees that: 
  
 (a) the Company will prepare the Final Memorandum in a form approved by the Initial Purchasers and will make
no amendment or supplement to the Final Memorandum to which the Initial Purchasers reasonably objects; 

 (b) promptly, from time to time, the Company will take such action as the Initial
Purchasers may reasonably request to qualify the Notes and the Shares for offering and sale under the securities laws of such jurisdictions as the Initial Purchasers may request, and the Company will comply with such laws so as to permit the
continuance of sales and dealing therein in such jurisdictions for as long as may be necessary to complete the distribution of the Notes; the Company will promptly advise the Initial Purchasers of the receipt by the Company of any notification with
respect to the suspension of the qualification of the Notes or the Shares for offer or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; provided, however, that in connection therewith the
Company shall not be required to qualify as a foreign corporation or execute a general consent to service of process; 
  
 (c) the Company will furnish the Initial Purchasers with as many copies of the Final Memorandum, any documents incorporated by reference
therein and any amendment or supplement thereto as the Initial Purchasers may from time to time reasonably request, and if, at any time prior to the completion of the resale of the Notes by the Initial Purchasers, any event shall have occurred as a
result of which the Final Memorandum as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made when such Final Memorandum is delivered, not misleading, or, if for any other reason it shall be necessary or desirable during such same period to amend or supplement the Final Memorandum, the Company will promptly notify the
Initial Purchasers and, upon the request of the Initial Purchasers, will prepare and furnish without charge to the Initial Purchasers and to any dealer in securities as many copies as the Initial Purchasers may from time to time reasonably request
of an amended Final Memorandum or a supplement to the Final Memorandum which will correct such statement or omission or otherwise effect compliance with this Section 5(c); 
  
 (d) at any time when the Company is not subject to Section 13 or 15(d) of the Exchange Act and so long
as any of the Notes (or Shares issued upon conversion thereof) (or any shares of Common Stock paid as part of any “Make-Whole Premium” (as defined in the Indenture)) are “restricted securities” within the meaning of Rule
144(a)(3) under the Act, for the benefit of holders from time to time of the Notes, the Company will furnish at its expense, upon request, to holders and beneficial owners of Notes and prospective purchasers of Notes information satisfying the
requirements of subsection (d)(4)(i) of Rule 144A; 
  
 (e) until the completion of the resale of the Notes by the Initial Purchasers, the Company will (i) file promptly all reports and any proxy or information statement required to be filed by the Company with the Commission in order to
comply with the Exchange Act and (ii) promptly notify you of such filing; 

 (f) the Company will use its best efforts to cause the Notes to be eligible for trading
in PORTAL; 
  
 (g) for so long as any Notes
remain outstanding, the Company will furnish to the Initial Purchasers copies of all reports or other communications (financial or other) furnished to stockholders of the Company, and will deliver to the Initial Purchasers (i) as soon as they
are available, copies of any reports and financial statements furnished to or filed by the Company with the Commission or any securities exchange on which the Notes or any class of securities of the Company is listed; and (ii) such additional
information concerning the business and financial condition of the Company as the Initial Purchasers may from time to time reasonably request (such financial statements to be on a consolidated basis to the extent the accounts of the Company and its
subsidiaries are consolidated in reports furnished to its stockholders generally or to the Commission); 
  
 (h) the Company will use the net proceeds received by it from the sale of the Notes pursuant to this Agreement in the manner specified in
the Final Memorandum under the caption “Use of proceeds”; 
  
 (i) the Company will reserve and keep available at all times free of preemptive rights, Shares for the purpose of enabling the Company to satisfy any obligations to issue Shares upon conversion of the Notes;

  
 (j) the Company will use its best efforts to
list, as promptly as practicable but in no event later than the time that the initial registration statement to be filed with the Commission pursuant to the Registration Rights Agreement is declared effective in accordance with the Registration
Rights Agreement, the Shares on the NASDAQ, and to maintain such listing; 
  
 (k) the Company will not, and will cause its Subsidiaries not to, take, directly or indirectly, any action designed, or which has constituted or might reasonably be expected to cause or result in, under the Exchange
Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Notes or the Shares issuable upon conversion of the Notes; 
  
 (l) whether or not the transactions contemplated in this
Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including, without limitation, (i) the fees, disbursements and
expenses of the Company’s counsel and the Company’s accountants in connection with the issuance and sale of the Notes and all other fees and expenses in connection with the preparation of each Memorandum and all amendments and supplements
thereto, including all printing costs associated therewith, and the furnishing of copies thereof to the Initial Purchasers and to dealers (including costs of mailing and shipment); (ii) all costs related to the preparation, issuance, execution,
authentication and delivery of the Notes and the Shares, (iii) all costs related to the transfer and delivery of the Notes to the Initial Purchasers, including any 

 
transfer or other taxes payable thereon; (iv) the word processing and/or printing charges and expenses of counsel to the Initial Purchasers (but not
including its fees for professional services) of this Agreement, the Indenture and the Registration Rights Agreement, and the reproduction and/or printing and furnishing of copies thereof to the Initial Purchasers and to dealers (including costs of
mailing and shipment); (v) all expenses in connection with the qualification of the Notes and the Shares for offering and sale under state or foreign laws, the determination of their eligibility for investment under state or foreign law and the
cost of printing and furnishing of copies of any blue sky or legal investment memorandum to the Initial Purchasers and to dealers (including filing fees and the fees and disbursements of counsel for the Initial Purchasers in connection with such
qualification and in connection with such blue sky or legal investment memorandum); (vi) any filing for review of the offering of the Notes or the Shares by the NASD, including the legal fees and filing fees and other disbursements of counsel
to the Initial Purchasers relating to NASD matters; (vii) any fees payable to investment rating agencies with respect to the rating of the Notes; (viii) the costs and charges of the Trustee and any transfer agent, registrar or depositary;
(ix) the fees and expenses, if any, incurred in connection with the admission of the Notes for trading in PORTAL or any appropriate market system; (x) any listing of the Shares on any securities exchange or qualification of the Shares for
quotation on the NASDAQ; (xi) the costs and expenses of the Company relating to presentations or meetings undertaken in connection with the marketing of the offering of the Notes to prospective investors and the Initial Purchasers’ sales
forces, including, without limitation, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations, travel, lodging and other expenses incurred
by the officers of the Company and any such consultants, and the cost of any aircraft chartered in connection with the road show; (xii) the costs and expenses of qualifying the Notes for inclusion in the book-entry settlement system of the
Depositary Trust Company (the “DTC”); and (xiii) all other costs and expenses incident to the performance of the Company’s obligations hereunder for which provision is not otherwise made in this Section 5(l);

  
 (m) the Company will (i) cause the
Notes, and the Shares issuable upon conversion of the Notes, to be included in the book-entry settlement system of the DTC and (ii) comply with all of its obligation set forth in the representations letter of the Company to the DTC relating to
such inclusion; 
  
 (n) neither the Company nor
any Affiliate or Subsidiary of the Company will sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in the Act), which sale, offer, solicitation or negotiation could be integrated with the sale
of the Notes in a manner which would require their registration under the Act of the Notes; 
  
 (o) the Company will not solicit any offer to buy or offer or sell the Notes or the Shares by means of any form of “general
solicitation” or “general advertising” (as those terms are used in Regulation D under the Act) or in any manner involving a public offering within the meaning of Section 4(2) of the Act; 

 (p) during the period of two years after the time of purchase or the additional time of
purchase, if later, the Company will not, and will not permit any of its “affiliates” (as defined in Rule 144 under the Act (“Rule 144”)) to, resell any of the Notes or the Shares which constitute “restricted
securities” under Rule 144 that have been reacquired by any of them; 
  
 (q) the Company will not take any action prohibited by Regulation M under the Exchange Act in connection with the distribution, as contemplated hereby, of the Notes; 
  
 (r) the Company will furnish to you as early as practicable
prior to the time of purchase and any additional time of purchase, as the case may be, but not later than two business days prior thereto, a copy of the latest available unaudited interim and monthly consolidated financial statements, if any, of the
Company and the Subsidiaries which have been read by the Company’s independent certified public accountants, as stated in their letter to be furnished pursuant to Section 7(c) hereof; 
  
 (s) the Company will not, at any time on or after the
execution of this Agreement, distribute any “prospectus” (within the meaning of the Act) or offering material in connection with the offering or sale of the Notes other than the then most recent Final Memorandum; 
  
 (t) during the period (the “Lock-Up
Period”) beginning from the date hereof and ending on, and including, the date that is 90 days after the date of the Final Memorandum, the Company will not, without the prior written consent of UBS, (i) issue, offer, sell, agree to
sell, hypothecate, pledge or otherwise dispose of, or contract to dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the
Exchange Act and the rules and regulations of the Commission promulgated thereunder, with respect to, any shares of Common Stock, any securities substantially similar to the Notes or the Common Stock, any securities that are convertible into or
exercisable or exchangeable for shares of Common Stock, any debt securities or any securities that are convertible into or exercisable or exchangeable for the Notes or such other debt securities, (ii) file or cause to be declared effective a
registration statement under the Act relating to the offer and sale of any shares of Common Stock or securities convertible into or exercisable or exchangeable for Common Stock or warrants or other rights to purchase Common Stock or any other
securities of the Company that are substantially similar to Common Stock, (iii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of Common Stock, any
securities substantially similar to the Notes or the Common Stock, any securities that are convertible into or exercisable or exchangeable for shares of Common Stock, any debt securities or any securities that are convertible into or exercisable or
exchangeable for the Notes or such other debt securities, whether any such transaction is to be settled by delivery of Common Stock or such other securities, in cash or otherwise, (iv) publicly announce an intention to effect any transaction
specified in clause (i), (ii) or 

 
(iii), or (v) waive any rights of the Company in respect of any lockup arrangement or similar agreement restricting the transfer of Common Stock held by
ValueAct Partners, L.L.C. or any of its Affiliates or the release of ValueAct Partners, L.L.C. or any of its Affiliates from their respective obligations under any such arrangement or agreement, except in the case of clauses (i) through
(iv) for (A) the issuance of the Notes; (B) the issuance of Shares upon conversion of the Notes; (C) the issuance of Common Stock upon the exercise of options or warrants disclosed as outstanding in the Final Memorandum;
(D) the issuance of employee stock options not exercisable during the Lock-Up Period pursuant to stock option plans described in the Final Memorandum; (E) the issuance of Common Stock under the Company’s Employee Stock Purchase Plan
described in the Final Memorandum; (F); the issuance of Common Stock as consideration in mergers, stock or asset acquisitions or other business combinations to the extent the persons receiving such Common Stock enter into a Lock-Up Agreement
(provided that such issuances of Common Stock shall be permitted up to an aggregate of 5% of the Company’s total outstanding Common Stock as of the date hereof without the recipient thereof entering into a Lockup Agreement); and (G) the
filing, and effectiveness, under the Act of the registration statement to be filed with the Commission pursuant to the Registration Rights Agreement; and 
  
 (u) the Company will maintain a transfer agent and, if necessary under the jurisdiction of incorporation of the Company, a registrar for
the Common Stock. 
  
 6. Reimbursement of the Initial
Purchasers’ Expenses. If the Notes are not delivered for any reason other than termination of this Agreement pursuant to the default by the Initial Purchasers in their or their respective obligations hereunder, the Company shall, in
addition to paying the amounts described in Section 5(l) hereof, reimburse the Initial Purchasers for all of their out-of-pocket expenses, including the fees and disbursements of their counsel. 
  
 7. Conditions of the Initial Purchasers’ Obligations. The several
obligations of the Initial Purchasers hereunder are subject to the accuracy of the representations and warranties on the part of the Company on the date hereof, at the time of purchase and, if applicable, at the additional time of purchase, the
performance by the Company of its obligations hereunder and to the following additional conditions precedent: 
  
 (a) The Company shall furnish to you at the time of purchase and, if applicable, at the additional time of purchase, an opinion of
Stradling Yocca Carlson & Rauth, counsel for the Company, addressed to the Initial Purchasers, and dated the time of purchase or the additional time of purchase, as the case may be, with executed copies for the Initial Purchasers, and in
form and substance satisfactory to Willkie Farr & Gallagher LLP, counsel for the Initial Purchasers, in the form set forth in Exhibit B hereto. 
  

(b) The Company shall furnish to you at the time of purchase and, if applicable, at the additional time of purchase, a certificate of
James J. Sullivan in his capacity as Senior Vice President and General Counsel of the Company in the form set forth in Exhibit C hereto. 

 (c) You shall have received from Ernst & Young LLP letters dated, respectively,
the date of this Agreement, the time of purchase and, if applicable, the additional time of purchase, and addressed to the Initial Purchasers (with executed copies for the Initial Purchasers) in the forms approved by UBS. 
  
 (d) You shall have received at the time of purchase and, if
applicable, at the additional time of purchase, the favorable opinion of Willkie Farr & Gallagher LLP, counsel for the Initial Purchasers, dated the time of purchase or the additional time of purchase, as the case may be, in form and
substance reasonably satisfactory to UBS. 
  
 (e)
No amendment or supplement to either the Preliminary Memorandum or the Final Memorandum, or any document which upon filing with the Commission would be incorporated by reference in either Memorandum, shall at any time have been made or filed to
which you have objected or shall object in writing. 
  
 (f) At the time of purchase or the additional time of purchase, as the case may be, the Final Memorandum shall not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they are made, not misleading. 
  
 (g) Between the time of execution of this Agreement and the time of purchase or the additional time of purchase, as the case may be,
(A) no material adverse change or any development involving a prospective material adverse change in the business, properties, management, financial condition or results of operations of the Company and the Subsidiaries taken as a whole shall
occur or become known and (B) no transaction which is material and adverse to the Company has been entered into by the Company or any of the Subsidiaries. 
  

(h) The Company will, at the time of purchase and, if applicable, at the additional time of purchase, deliver to you a certificate of
its Chief Executive Officer and its Chief Financial Officer, dated the time of purchase or the additional time of purchase, as the case may be, in the form attached as Exhibit D hereto. 
  
 (i) The Company will, at the time of purchase and, if
applicable, at the additional time of purchase, deliver to you a certificate of its Chief Financial Officer, dated the time of purchase or the additional time of purchase, as the case may be, in the form attached as Exhibit E. 
  
 (j) You shall have received copies, duly executed by the
Company and the other parties thereto, of the Indenture and the Registration Rights Agreement. 
  
 (k) You shall have received each of the signed Lock-Up Agreements referred to in Section 3(z) hereof, and each such Lock-Up Agreement
shall be in full force and effect at the time of purchase and the additional time of purchase, as the case may be. 

 (l) The Company shall have furnished to you such other documents and certificates as to
the accuracy and completeness of any statement in the Final Memorandum as of the time of purchase and, if applicable, the additional time of purchase, as you may reasonably request. 
  
 (m) The Notes shall have been designated for trading on PORTAL, subject only to notice of issuance at or
prior to the time of purchase. 
  
 (n) Between
the time of execution of this Agreement and the time of purchase or additional time of purchase, as the case may be, there shall not have occurred any downgrading, nor shall any notice have been given of (i) any intended or potential
downgrading or (ii) any watch, review or possible change that does not indicate an affirmation or improvement in the rating accorded any debt securities of or guaranteed by the Company or any Subsidiary by any “nationally recognized
statistical rating organization,” as that term is defined in Rule 436(g)(2) under the Act. 
  
 8. Effective Date of Agreement; Termination. This Agreement shall become effective when the parties hereto have executed and delivered this
Agreement. 
  
 The obligations of the Initial Purchasers hereunder
shall be subject to termination in the absolute discretion of the Initial Purchasers if (x) since the time of execution of this Agreement or the earlier respective dates as of which information is given in the Final Memorandum, there has been
any material adverse change or any development involving a prospective material adverse change in the business, properties, management, financial condition or results of operations of the Company and the Subsidiaries taken as a whole, which would,
in the Initial Purchasers’ judgment make it impracticable or inadvisable to proceed with the offering or the delivery of the Notes on the terms and in the manner contemplated in the Final Memorandum, or (y) since the time of execution of
this Agreement, there shall have occurred: (i) a suspension or material limitation in trading in securities generally on the New York Stock Exchange, the American Stock Exchange or the NASDAQ; (ii) a suspension or material limitation in
trading in the Company’s securities on the NASDAQ; (iii) a general moratorium on commercial banking activities declared by either federal or New York State authorities or a material disruption in commercial banking or securities settlement
or clearance services in the United States; (iv) an outbreak or escalation of hostilities or acts of terrorism involving the United States or a declaration by the United States of a national emergency or war; or (v) any other calamity or
crisis or any change in financial, political or economic conditions in the United States or elsewhere, if the effect of any such event specified in clause (iv) or (v), in the Initial Purchasers’ judgment makes it impracticable or
inadvisable to proceed with the offering or the delivery of the Notes on the terms and in the manner contemplated in the Final Memorandum, or (z) since the time of execution of this Agreement, there shall have occurred any downgrading, or any
notice or announcement shall have been given or made of (i) any intended or potential downgrading or (ii) any watch, review or possible change that does not indicate an affirmation or improvement in the rating accorded any debt securities
of or guaranteed by the Company or any Subsidiary by any “nationally recognized statistical rating organization,” as that term is defined in Rule 436(g)(2) under the Act. 

 If the Initial Purchasers elects to terminate this Agreement as provided in this Section 8, the
Company shall be notified promptly in writing. 
  
 If the sale to
the Initial Purchasers of the Notes, as contemplated by this Agreement, is not carried out by the Initial Purchasers for any reason permitted under this Agreement, or if such sale is not carried out because the Company shall be unable to comply with
any of the terms of this Agreement, the Company shall not be under any obligation or liability under this Agreement (except to the extent provided in Sections 5(l), 6 and 9 hereof), and the Initial Purchasers shall be under no obligation or
liability to the Company under this Agreement. 
  
 9. Indemnity
and Contribution. 
  
 (a) The Company agrees
to indemnify, defend and hold harmless the Initial Purchasers, their partners, directors and officers, and any person who controls the Initial Purchasers within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, and
the successors and assigns of all of the foregoing persons, from and against any loss, damage, expense, liability or claim (including the reasonable cost of investigation) which the Initial Purchasers or any such person may incur under the Act, the
Exchange Act, the common law or otherwise, insofar as such loss, damage, expense, liability or claim arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained or incorporated by reference
in any Memorandum, as amended or supplemented, if applicable, or arises out of or is based upon any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements made therein, in the light of
the circumstances under which they were made, not misleading, except insofar as any such loss, damage, expense, liability or claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in, and
in conformity with information concerning the Initial Purchasers furnished in writing by or on behalf of the Initial Purchasers to the Company expressly for use in, such Memorandum; or (ii) any untrue statement or alleged untrue statement made
by the Company in Section 3 hereof or the failure by the Company to perform when and as required any agreement or covenant contained herein. 
  
 If any action, suit or proceeding (each, a “Proceeding”) is brought against the Initial Purchasers or any such person in
respect of which indemnity may be sought against the Company pursuant to the foregoing paragraph, the Initial Purchasers or such person shall promptly notify the Company in writing of the institution of such Proceeding and the Company shall assume
the defense of such Proceeding, including the employment of counsel reasonably satisfactory to such indemnified party and payment of all fees and expenses; provided, however, that the omission to so notify the Company shall not relieve
the Company from any liability which the Company may have to the Initial Purchasers or any such person or otherwise, unless the Company is materially prejudiced as a result of such omission, and then only to the extent of such prejudice. The Initial
Purchasers or such person shall have the right to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the 

 
expense of the Initial Purchasers or of such person unless the employment of such counsel shall have been authorized in writing by the Company in connection
with the defense of such Proceeding or the Company shall not have, within a reasonable period of time in light of the circumstances, employed counsel to have charge of the defense of such Proceeding or such indemnified party or parties shall have
reasonably concluded that there may be defenses available to it or them which are different from, additional to or in conflict with those available to the Company (in which case the Company shall not have the right to direct the defense of such
Proceeding on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by the Company and paid as incurred (it being understood, however, that the Company shall not be liable for the expenses of more
than one separate counsel (in addition to any local counsel) in any one Proceeding or series of related Proceedings in the same jurisdiction representing the indemnified parties who are parties to such Proceeding). The Company shall not be liable
for any settlement of any Proceeding effected without its written consent but, if settled with the written consent of the Company, the Company agrees to indemnify and hold harmless the Initial Purchasers and any such person from and against any loss
or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by
the second sentence of this paragraph, then the indemnifying party agrees that it shall be liable for any settlement of any Proceeding effected without its written consent if (i) such settlement is entered into more than 60 business days after
receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall not have fully reimbursed the indemnified party in accordance with such request and as required by this Agreement prior to the date of such
settlement and (iii) such indemnified party shall have given the indemnifying party at least 30 days’ prior notice of its intention to settle. No indemnifying party shall, without the prior written consent of the indemnified party, effect
any settlement of any pending or threatened Proceeding in respect of which any indemnified party is or reasonably could have been expected to be a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement
includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such Proceeding and does not include an admission of fault or culpability or a failure to act by or on behalf of such indemnified
party. 
  
 (b) Each Initial Purchaser severally
agrees to indemnify, defend and hold harmless the Company, its directors and officers, and any person who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, and the successors and assigns of
all of the foregoing persons, from and against any loss, damage, expense, liability or claim (including the reasonable cost of investigation) which, jointly or severally, the Company or any such person may incur under the Act, the Exchange Act, the
common law or otherwise, insofar as such loss, damage, expense, liability or claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in, and in conformity with information concerning such
Initial Purchaser furnished in writing by or on behalf of such Initial Purchaser to the Company expressly for use in, any Memorandum, or arises out of or is based upon any omission or alleged omission to state a material fact in connection with such
information required to be stated in any Memorandum or necessary to make such information not misleading. 

 If any Proceeding is brought against the Company or any such person in respect of which
indemnity may be sought against any Initial Purchaser pursuant to the foregoing paragraph, the Company or such person shall promptly notify such Initial Purchaser in writing of the institution of such Proceeding and such Initial Purchaser shall
assume the defense of such Proceeding, including the employment of counsel reasonably satisfactory to such indemnified party and payment of all fees and expenses; provided, however, that the omission to so notify such Initial Purchaser
shall not relieve such Initial Purchaser from any liability which such Initial Purchaser may have to the Company or any such person or otherwise, unless such Initial Purchaser is materially prejudiced as a result of such omission, and then only to
the extent of such prejudice. The Company or such person shall have the right to employ its own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of the Company or such person unless the employment of such
counsel shall have been authorized in writing by such Initial Purchaser in connection with the defense of such Proceeding or such Initial Purchaser shall not have, within a reasonable period of time in light of the circumstances, employed counsel to
defend such Proceeding or such indemnified party or parties shall have reasonably concluded that there may be defenses available to it or them which are different from or additional to or in conflict with those available to such Initial Purchaser
(in which case such Initial Purchaser shall not have the right to direct the defense of such Proceeding on behalf of the indemnified party or parties, but such Initial Purchaser may employ counsel and participate in the defense thereof but the fees
and expenses of such counsel shall be at the expense of such Initial Purchaser), in any of which events such fees and expenses shall be borne by such Initial Purchaser and paid as incurred (it being understood, however, that such Initial Purchaser
shall not be liable for the expenses of more than one separate counsel (in addition to any local counsel) in any one Proceeding or series of related Proceedings in the same jurisdiction representing the indemnified parties who are parties to such
Proceeding). No Initial Purchaser shall be liable for any settlement of any such Proceeding effected without the written consent of such Initial Purchaser but, if settled with the written consent of such Initial Purchaser, such Initial Purchaser
agrees to indemnify and hold harmless the Company and any such person from and against any loss or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an
indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by the second sentence of this paragraph, then the indemnifying party agrees that it shall be liable for any settlement of any Proceeding effected
without its written consent if (i) such settlement is entered into more than 60 business days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall not have reimbursed the indemnified party
in accordance with such request and as required by this Agreement prior to the date of such settlement and (iii) such indemnified party shall have given the indemnifying party at least 30 days’ prior notice of its intention to settle. No
indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened Proceeding in respect of which any indemnified party is or reasonably could have been expected to be a 

 
party and indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified
party from all liability on claims that are the subject matter of such Proceeding. 
  
 (c) If the indemnification provided for in this Section 9 is unavailable to an indemnified party under subsections (a) and
(b) of this Section 9 or insufficient to hold an indemnified party harmless in respect of any losses, damages, expenses, liabilities or claims referred to therein, then each applicable indemnifying party shall contribute to the amount paid
or payable by such indemnified party as a result of such losses, damages, expenses, liabilities or claims (i) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Initial
Purchasers on the other hand from the offering of the Notes or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred
to in clause (i) above but also the relative fault of the Company on the one hand and of the Initial Purchasers on the other in connection with the statements or omissions which resulted in such losses, damages, expenses, liabilities or claims,
as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Initial Purchasers on the other shall be deemed to be in the same respective proportions as the total proceeds from the
offering (net of the Initial Purchasers’ discounts and commissions but before deducting expenses) received by the Company, and the total discounts and commissions received by the Initial Purchasers, bear to the gross proceeds to the Company
from the offering of the Notes (before deducting the Initial Purchasers’ discounts and commissions and other expenses). The relative fault of the Company on the one hand and of the Initial Purchasers on the other shall be determined by
reference to, among other things, whether the untrue statement or alleged untrue statement of a material fact or omission or alleged omission relates to information supplied by the Company or by the Initial Purchasers and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The amount paid or payable by a party as a result of the losses, damages, expenses, liabilities and claims referred to in this subsection
shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with investigating, preparing to defend or defending any Proceeding. 
  
 (d) The Company and the Initial Purchasers agree that it would not be just and equitable if contribution
pursuant to this Section 9 were determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations
referred to in subsection (c) above. Notwithstanding the provisions of this Section 9, no Initial Purchaser shall be required to contribute any amount in excess of the amount by which the total price at which the Notes resold by it in the
initial placement of such Notes were offered to investors exceeds the amount of any damage which such Initial Purchaser has otherwise been required to pay by reason of such untrue statement or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 

 (e) The indemnity and contribution agreements contained in this Section 9 and the
covenants, warranties and representations of the Company contained in this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of any Initial Purchaser, its partners, directors or officers or any
person (including each partner, officer or director of such person) who controls such Initial Purchaser within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, or by or on behalf of the Company, its directors or
officers or any person who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, and shall survive any termination of this Agreement or the issuance and delivery of the Notes. The Company and
the Initial Purchasers agree promptly to notify each other of the commencement of any Proceeding against it and, in the case of the Company, against any of the Company’s officers or directors in connection with the issuance and sale of the
Notes, or in connection with any Memorandum. 
  
 10.
Information Furnished by the Initial Purchasers. The statements set forth in the thirteenth paragraph under the caption “Plan of distribution” in the Final Memorandum, only insofar as such statements relate to over-allotment and
stabilization, constitute the only information furnished by or on behalf of the Initial Purchasers as such information is referred to in Sections 3 and 9 hereof. 
  
 11. Notices. Except as otherwise herein provided, all statements, requests, notices and agreements shall be in
writing or by telegram or facsimile and, if to the Initial Purchasers, shall be sufficient in all respects if delivered or sent to UBS Securities LLC, 299 Park Avenue, New York, NY 10171-0026, Attention: Syndicate Department and, if to the Company,
shall be sufficient in all respects if delivered or sent to the Company at the offices of the Company at 567 Nicolas Drive, Suite 360, Newport Beach, CA 92661, Attention: Chief Financial Officer. 
  
 12. Governing Law; Construction. This Agreement and any claim,
counterclaim or dispute of any kind or nature whatsoever arising out of or in any way relating to this Agreement (“Claim”), directly or indirectly, shall be governed by, and construed in accordance with, the laws of the State of New
York. The section headings in this Agreement have been inserted as a matter of convenience of reference and are not a part of this Agreement. 
  
 13. Submission to Jurisdiction. Except as set forth below, no Claim may be commenced, prosecuted or continued in any court other than the courts of
the State of New York located in the City and County of New York or in the United States District Court for the Southern District of New York, which courts shall have jurisdiction over the adjudication of such matters, and the Company consents to
the jurisdiction of such courts and personal service with respect thereto. The Company hereby consents to personal jurisdiction, service and venue in any court in which any Claim arising out of or in any way relating to this Agreement is brought by
any third party against the Initial Purchasers or any indemnified party. The Initial Purchasers and the Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) waive all right to trial by
jury in any action, proceeding or counterclaim (whether based upon contract, tort or otherwise) in any way arising out of or relating to this Agreement. The Company agrees that a final judgment in any such action, proceeding or counterclaim brought
in any such court shall be conclusive and binding upon the Company and may be enforced in any other courts to the jurisdiction of which the Company is or may be subject, by suit upon such judgment. 

 14. Parties at Interest. The Agreement herein set forth has been and is made solely for the
benefit of the Initial Purchasers and the Company and to the extent provided in Section 9 hereof the controlling persons, partners, directors and officers referred to in such Section, and their respective successors, assigns, heirs, personal
representatives and executors and administrators. No other person, partnership, association or corporation (including a purchaser, as such purchaser, from the Initial Purchasers) shall acquire or have any right under or by virtue of this Agreement.

  
 15. Counterparts. This Agreement may be signed by the
parties in one or more counterparts which together shall constitute one and the same agreement among the parties. 
  
 16. Successors and Assigns. This Agreement shall be binding upon the Initial Purchasers and the Company and their successors and assigns and any
successor or assign of any substantial portion of the Company’s and any of the Initial Purchasers’ respective businesses and/or assets. 
  
 17. Miscellaneous. UBS, an indirect, wholly owned subsidiary of UBS AG, is not a bank and is separate from any affiliated bank, including any U.S.
branch or agency of UBS AG. Because UBS is a separately incorporated entity, it is solely responsible for its own contractual obligations and commitments, including obligations with respect to sales and purchases of securities. Securities sold,
offered or recommended by UBS are not deposits, are not insured by the Federal Deposit Insurance Corporation, are not guaranteed by a branch or agency, and are not otherwise an obligation or responsibility of a branch or agency. 
  
 18. No Fiduciary Duties.. The Company hereby acknowledges that the
Initial Purchasers are acting solely as initial purchasers in connection with the purchase and sale of the Company’s securities. The Company further acknowledges that the Initial Purchasers are acting pursuant to a contractual relationship
created solely by this Purchase Agreement entered into on an arm’s length basis and in no event do the parties intend that the Initial Purchasers act or be responsible as fiduciaries to the Company, its management, stockholders, creditors or
any other person in connection with any activity that the Initial Purchasers may undertake or have undertaken in furtherance of the purchase and sale of the Company’s securities, either before or after the date hereof. The Initial Purchasers
hereby expressly disclaim any fiduciary or similar obligations to the Company, either in connection with the transactions contemplated by this Purchase Agreement or any matters leading up to such transactions, and the Company hereby confirms its
understanding and agreement to that effect. The Company and the Initial Purchasers agree that they are each responsible for making their own independent judgments with respect to any such transactions, and that any opinions or views with respect to
the price or market for the Company’s securities, do not constitute advice or recommendations to the Company. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the
Initial Purchasers with respect to any breach or alleged breach of any fiduciary duty to the Company in connection with the transactions contemplated by this Purchase Agreement or any matters leading up to such transactions. 

 [The Remainder of This Page Intentionally Left Blank; Signature Page Follows] 

 If the foregoing correctly sets forth the understanding between the Company and the Initial Purchasers,
please so indicate in the space provided below for that purpose, whereupon this Agreement and your acceptance shall constitute a binding agreement between the Company and the Initial Purchasers. 
  

			
	 Very truly yours,

	
	 THE TRIZETTO GROUP, INC.

		
	 By:
	 	  

	 Name:
	 	 
	 Title:
	 	 

 Accepted and agreed to as of the date 
 first above written: 
  

			
	 UBS SECURITIES LLC

		
	By:	 	  

	Name:	 	 
	Title:	 	 
		
	By:	 	  

	Name:	 	 
	Title:	 	 

 SCHEDULE A 
  

				
	 Initial Purchaser

	  	Principal
Amount of
Firm Notes

	 UBS SECURITIES LLC
	  	$	60,000,000
	 BANC OF AMERICA SECURITIES LLC
	  	 	30,000,000
	 WILLIAM BLAIR & COMPANY, L.L.C.
	  	 	10,000,000
	 	  	
	

	 Total
	  	$	100,000,000
	 	  	
	

 EXHIBIT A 
  
 Lock-Up Agreement 
  
 September     , 2005 
  
 UBS Securities LLC 
 on behalf of the Initial Purchasers 
 c/o UBS Securities LLC 
 299 Park Avenue 
 New York, New York 10171-0026 
  
 Ladies
and Gentlemen: 
  
 This Lock-Up Agreement is being delivered to
you in connection with the proposed Purchase Agreement (the “Purchase Agreement”) to be entered into by The TriZetto Group, Inc., a Delaware corporation (the “Company”), and you, with respect to the offering (the
“Offering”) without registration under the Securities Act of 1933, as amended (the “Act”), in reliance on Rule 144A under the Act, of Convertible Senior Notes due 2025 (the “Notes”) of the Company.
Capitalized terms used herein without definition shall have the respective meanings ascribed to them in the Purchase Agreement. 
  
 In order to induce you to enter into the Purchase Agreement, the undersigned agrees that, for a period (the “Lock-Up Period”) beginning
on the date hereof and ending on, and including, the date that is 90 days after the date of the final offering memorandum relating to the Offering, the undersigned will not, without the prior written consent of UBS Securities LLC, (i) sell,
offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or file (or participate in the filing of) a registration statement with the
Securities and Exchange Commission (the “Commission”) in respect of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities
Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder (the “Exchange Act”) with respect to, any common stock (the “Common Stock”), $0.001 par value per share, of
the Company or any securities convertible into or exercisable or exchangeable for Common Stock, or warrants or other rights to purchase Common Stock or any such securities, or any securities substantially similar to the Notes or Common Stock,
(ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or
any such securities, or warrants or other rights to purchase Common Stock, whether any such transaction is to be settled by delivery of Common Stock or such other securities, in cash or otherwise or (iii) publicly announce an intention to
effect any transaction specified in clause (i) or (ii). The foregoing sentence shall not apply to (a) bona fide gifts, provided the recipient thereof agrees in writing with the Initial Purchaser to be bound by the terms of this Lock-Up
Agreement, (b) dispositions to any trust for the direct or indirect benefit of the undersigned and/or the immediate family of the undersigned, 

  

 A-1 

 
provided that such trust agrees in writing with the Initial Purchaser to be bound by the terms of this Lock-Up Agreement, (c) transfers by will or
intestate succession, provided the successors agree in writing with the Initial Purchaser to be bound by this Lock-Up Agreement, (d) transfers to partners of a partnership or to members of a limited liability company, provided the successors
agree in writing with the Initial Purchaser to be bound by this Lock-Up Agreement [or (e) sales made pursuant to a 10b5-1 plan in existence as of the date of this Agreement]1. For purposes of this paragraph, “immediate family” shall mean the undersigned and the spouse, any lineal descendent, father, mother, brother or
sister of the undersigned. 
  
 In addition, the undersigned hereby
waives any rights the undersigned may have to require registration of Common Stock in connection with the filing of any registration statement to be filed with the Commission pursuant to the Registration Rights Agreement. The undersigned further
agrees that, for the Lock-Up Period, the undersigned will not, without the prior written consent of UBS Securities LLC, make any demand for, or exercise any right with respect to, the registration of Common Stock or any securities convertible into
or exercisable or exchangeable for Common Stock, or warrants or other rights to purchase Common Stock or any such securities. 
  
 The undersigned hereby confirms that the undersigned has not, directly or indirectly, taken, and hereby covenants that the undersigned will not, directly
or indirectly, take, any action designed, or which has constituted or will constitute or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of Notes or the shares of Common Stock issuable upon conversion of the Notes. 
  
 * * * 
  

	1	Clause (e) to be included only in the Lockup Agreement executed by Jeffrey H. Margolis 

  

 A-2 

 If (i) the Company notifies you in writing that it does not intend to proceed with the Offering,
(ii) for any reason the Purchase Agreement shall be terminated prior to the “time of purchase” (as defined in the Purchase Agreement) or (iii) the Purchase Agreement is not entered into between you and the Company by
December 31, 2005, this Lock-Up Agreement shall be terminated and the undersigned shall be released from its obligations hereunder. 
  

	
	Yours very truly,
	  
  

	Name:

  

 A-3 

 EXHIBIT A-1 
  
 LIST OF PARTIES TO EXECUTE LOCK-UP AGREEMENTS 
  

			
	 Name

	 	 Position

	 1. Anthony Bellomo
	 	 Executive Vice President — Enterprise Software

		
	 2. Kathleen Early
	 	 President and Chief Operating Officer

		
	 3. Lois A. Evans
	 	 Director

		
	 4. Richard M. Fitzgerald
	 	 Vice President — Benefits Administration Services and Operations

		
	 5. Patricia E. Gorman
	 	 Executive Vice President — Business Solutions

		
	 6. Thomas B. Johnson
	 	 Director

		
	 7. L. William Krause
	 	 Director

		
	 8. Paul F. LeFort
	 	 Director

		
	 9. Donald J. Lothrop
	 	 Director

		
	 10. James C. Malone
	 	 Senior Vice President — Finance

		
	 11. Jeffrey H. Margolis
	 	 Chairman of the Board, CEO and President

		
	 12. James J. Sullivan
	 	 Senior Vice President, General Counsel

		
	 13. Philip J. Tamminga
	 	 Executive Vice President — Professional Services

		
	 14. James D. Wade
	 	 Senior Vice President — Human Capital Management

		
	 15. Jerry P. Widman
	 	 Director

  

 A-1 

 EXHIBIT B 
  
 OPINION OF STRADLING YOCCA CARLSON & RAUTH 
  
                     , 2005 
  
 UBS Securities LLC  
 Banc of America Securities LLC 
 William Blair & Company, L.L.C. 
 as initial purchasers 
 c/o UBS Securities LLC 
 299 Park Avenue 
 New York, New York 10171-0026 
  
 Re:     The Trizetto Group, Inc. 
  
 Ladies and Gentlemen: 
  
 We have acted as counsel to the Trizetto Group, Inc., a Delaware corporation (the “Company”), in connection with
(i) the Offering Memorandum, dated                     , 2005 (the “Final Memorandum”), and (ii) the Purchase Agreement,
dated                     , 2005 (the “Purchase Agreement”), by and among the Company and UBS Securities LLC, Banc of America
Securities LLC and William Blair & Company, L.L.C. (the “Initial Purchasers”), pursuant to which (a) the Company has agreed to sell to the Initial Purchasers, and the Initial Purchasers have agreed to purchase from the
Company, $                     aggregate principal amount of its
            % Senior Convertible Notes due 2025 (the “Notes”) and (b) the Company granted an option to the Initial Purchasers to purchase up to an additional
$                     aggregate principal amount of the Notes. This opinion is being delivered pursuant to Section 7(a) of the Purchase
Agreement. Unless specifically defined herein or the context requires otherwise, capitalized terms used herein shall have the meanings set forth in the Purchase Agreement. 
  
 In connection with the preparation of this opinion, we have examined such documents and considered such questions of law as
we have deemed necessary or appropriate. We have assumed that, except for the Purchase Agreement, the Indenture, the Registration Rights Agreement, and the documents required or contemplated thereby and the documents delivered on the date hereof in
connection with the closing under the Purchase Agreement, there are no other documents or agreements between the Company and the Initial Purchasers which would expand or otherwise modify the respective rights and obligations of the Company and the
Initial Purchasers as set forth in the Purchase Agreement, the Indenture and the Registration Rights Agreement. 
  
 We have assumed the authenticity of all documents submitted to us as originals, the conformity with originals of all documents submitted to us as copies,
and the genuineness of all signatures (other than signatures of officers of the Company). We have also assumed that, with respect to all parties to agreements or instruments relevant hereto (other than the Company), such parties had the requisite
power and authority to execute, deliver and perform such agreements or instruments, that such agreements or instruments have been duly authorized by all requisite action, executed and delivered by such parties, and that such agreements or
instruments are the valid, binding and enforceable obligations of such parties. 
  

 B-1 

 As to questions of fact material to our opinions, we have relied upon the representations of each party
made in the Purchase Agreement and the other documents and certificates delivered in connection therewith, certificates of officers of the Company, and certificates and advice of public officials. In addition, the opinions regarding the
Company’s capitalization have been rendered solely in reliance upon certificates of officers of the Company and certificates from the Company’s transfer agent. 
  
 Whenever a statement herein is qualified by “known to us,” “to our current actual knowledge,” or similar
phrase, it is intended to indicate that, during the course of our representation of the Company, no information that would give us current actual knowledge of the inaccuracy of such statement has come to the attention of those attorneys currently
employed by this firm who have rendered legal services to the Company. However, except as otherwise expressly indicated, we have not undertaken any independent investigation to determine the accuracy of such statement, and any limited inquiry
undertaken by us during the preparation of this opinion letter should not be regarded as such an investigation; no inference as to our knowledge of any matters bearing on the accuracy of any such statement should be drawn from the fact of our
representation of the Company. 
  
 Based upon the foregoing, and
subject to the assumptions, exceptions, qualifications and limitations set forth herein, we are of the opinion that: 
  
 1. The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware, with full
corporate power and authority to own, lease and operate its properties and conduct its business as described in the Final Memorandum, to execute and deliver the Purchase Agreement, the Registration Rights Agreement, the Indenture and the Notes and
to perform its obligations thereunder, including, without limitation, to issue, sell and deliver the Notes and to issue and deliver the Shares upon conversion of the Notes. 
  
 2. Each of the Subsidiaries has been duly incorporated and is validly existing as a corporation in good standing under the
laws of its jurisdiction of incorporation, with full corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Final Memorandum. 
  
 3. The Company and the Subsidiaries are each duly qualified to do business as
a foreign corporation and are in good standing in each jurisdiction where the ownership or leasing of their respective properties or the conduct of their respective businesses requires such qualification, except where the failure to be so qualified
and in good standing would not, individually or in the aggregate, have a Material Adverse Effect. 
  
 4. The Purchase Agreement has been duly authorized, executed and delivered by the Company. 
  
 5. The Indenture has been duly authorized, executed and delivered by the Company and, assuming due authorization, execution
and delivery thereof by the Trustee, will constitute a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms, except as the enforceability thereof may be limited by (a) bankruptcy,
insolvency, reorganization, arrangement, moratorium or other similar rights relating to or affecting the rights of creditors and (b) general equitable principles, regardless of whether the issue of enforceability is considered in a proceeding
in equity or at law. 
  

 B-2 

 6. The Notes have been duly authorized by the Company and, when duly executed, issued and authenticated
in accordance with terms of the Indenture and delivered to and paid for by the Initial Purchasers as contemplated by the Purchase Agreement, will constitute valid and legally binding obligations of the Company enforceable against the Company
in accordance with their terms and will be entitled to the benefits of the Indenture and the Registration Rights Agreement, except as the enforceability thereof may be limited by (a) bankruptcy, insolvency, reorganization, arrangement,
moratorium or other similar rights relating to or affecting the rights of creditors and (b) general equitable principles, regardless of whether the issue of enforceability is considered in a proceeding in equity or at law. 
  
 7. The Registration Rights Agreement has been duly authorized, executed and
delivered by the Company and constitutes a valid and legally binding agreement of the Company, enforceable against the Company in accordance with its terms, except as the enforceability thereof may be limited by (a) bankruptcy, insolvency,
reorganization, arrangement, moratorium or other similar rights relating to or affecting the rights of creditors and (b) general equitable principles, regardless of whether the issue of enforceability is considered in a proceeding in equity or
at law. 
  
 8. The Shares into which the Notes are convertible at
the initial “Conversion Rate” (as defined in the Indenture), assuming the conditions for such conversion have been satisfied, have been duly authorized and validly reserved for issuance upon conversion of the Notes; and such Shares, when
issued and delivered upon conversion in accordance with the terms of the Notes and Indenture, will be duly and validly authorized, fully paid and non-assessable and free of statutory preemptive rights and, to our knowledge, contractual preemptive
rights, resale rights, rights of first refusal and similar rights, and the holders of such Shares will not be subject to personal liability by reason of being such holders. To our knowledge, except as disclosed in the Final Memorandum, no options,
warrants or other rights to purchase, agreements or other obligations to issue, or rights to convert any obligations into or exchange any securities for, shares of capital stock of or ownership interests in the Company are outstanding. 

 
 9. The Company has an authorized and outstanding capitalization as set
forth in the Final Memorandum under the caption “Capitalization”; all of the issued and outstanding shares of capital stock of the Company have been duly authorized and validly issued, are fully paid and non-assessable, and are free of
statutory preemptive rights and, to our knowledge, contractual preemptive rights, rights of first refusal and similar rights. 
  
 10. All of the outstanding shares of capital stock of each of the Subsidiaries have been duly authorized and validly issued, are fully paid and
non-assessable, and except as otherwise stated in the Final Memorandum, based solely upon our review of the stock records of the Subsidiaries, are owned by the Company or a wholly owned Subsidiary of the Company, in each case to our knowledge
subject to no security interest, other encumbrance or adverse claim, except for the security interests, other encumbrances and adverse claims described in the Final Memorandum, and to our knowledge, no options, warrants or other rights to purchase,
agreements or other obligations to issue or other rights to convert any obligation into shares of capital stock or ownership interests in the Subsidiaries are outstanding. 
  

 B-3 

 11. The terms of the Notes, the Indenture and the Registration Rights Agreement, and the capital stock of
the Company, including the Shares, each conform in all material respects to the descriptions thereof contained or incorporated by reference in the Final Memorandum. 
  
 12. To our knowledge, the Company satisfies all conditions for the use of a registration statement on Form S-3 under the
Act, including, without limitation, (A) the registrant requirements of General Instruction I.A of Form S-3 under the Act and the transaction requirements of General Instructions I.B.3 of Form S-3 under the Act and (B) to register the
Notes, and the Shares issuable upon conversion of the Notes, for resale in the manner contemplated by the Registration Rights Agreement and the Final Memorandum; 
  
 13. Each Incorporated Document at the time it was filed with the Commission, complied as to form in all material respects
with the requirements of the Exchange Act (except as to the financial statements and schedules, and other financial data or statistical data, contained in such Incorporated Document, as to which we express no opinion). 
  
 14. No approval, authorization, consent or order of or filing with any
federal, state or local governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other non-governmental regulatory authority, or approval of the stockholders of the Company, or
pursuant to any federal law, or the Delaware General Corporation Law, is required in connection with the issuance and sale by the Company of the Notes or the issuance of Shares upon conversion of the Notes or the consummation of the transactions as
contemplated by the Purchase Agreement, the Indenture, the Registration Rights Agreement or the Notes, other than (i) as may be required under the securities or blue sky laws of the various jurisdictions in which the Notes and the Shares are
being offered by the Initial Purchasers, under the listing requirements, by laws or rules or regulations of the National Association of Securities Dealers, Inc., the Nasdaq National Market and the PORTAL Market (as to which we express no opinion)
and (ii) as may be required by federal and state securities laws with respect to the Company’s obligations under the Registration Rights Agreement. 
  
 15. The execution, delivery and performance of the Purchase Agreement, the Indenture, the Registration Rights Agreement and the Notes, the consummation by
the Company of the transactions contemplated thereby and the issuance of the Notes and of Shares upon the conversion of the Notes do not and will not conflict with, result in any breach or violation of or constitute a default under (nor constitute
any event which with notice, lapse of time or both would result in any breach or violation of or constitute a default under or give the holder of any indebtedness (or a person acting on such holder’s behalf) the right to require the repurchase,
redemption or repayment of all or a part of such indebtedness under) (or result in the creation or imposition of a lien, charge or encumbrance on any property or assets of the Company or any Subsidiary pursuant to) (i) the charter or bylaws of
the Company or any of the Subsidiaries, or (ii) any indenture, mortgage, deed of trust, bank loan or credit agreement or other material evidence of indebtedness, or any material license, lease, contract or other agreement or instrument to which
the Company or any of the Subsidiaries is a party or by which any of them or any of their respective properties may be bound or affected and which is filed as an exhibit to any Incorporated Document, or (iii) any federal statute, rule or
regulation, any statute or regulation of the State of California, or the Delaware General Corporation Law, of a type which is typically applicable to transactions similar to those transactions contemplated by the Purchase Agreement or (iv) to
our knowledge, any decree, judgment or order applicable to the Company or any of the Subsidiaries or any of their respective properties. 
  

 B-4 

 16. To our knowledge, there are no affiliate transactions, off-balance sheet transactions, contracts,
licenses, agreements, leases or documents of a character which are required to be described in the Final Memorandum (assuming the Final Memorandum were a prospectus included in a registration statement under the Act) or any Incorporated Document or
to be filed as an exhibit to any Incorporated Document which have not been so described or filed as required. 
  
 17. To our knowledge, (i) the Company is not a party to any legal or governmental action or proceeding that challenges the validity or
enforceability, or seeks to enjoin the performance, of the Purchase Agreement, the Indenture, the Registration Rights Agreement or the Notes; and (ii) there are no actions, suits, claims, investigations or proceedings pending, threatened or
contemplated to which the Company or any of the Subsidiaries or any of their respective directors or officers is or would be a party or to which any of their respective properties is or would be subject at law or in equity, before or by any federal,
state, local or foreign governmental or regulatory commission, board, body, authority or agency which are required to be described in the Final Memorandum (assuming the Final Memorandum were a prospectus included in a registration statement under
the Act) or any Incorporated Document but are not so described as required. 
  
 18. Neither the Company nor any Subsidiary is and, after giving effect to the offering and sale of the Notes, neither will be an “investment company” or an entity “controlled” by an
“investment company,” as such terms are defined in the Investment Company Act. 
  
 19. The statements in the Final Memorandum under the headings, “Description of Other Indebtedness,” “Description of the Notes,” “Description of Capital Stock,” “Plan of
Distribution,” and “Transfer Restrictions”, insofar as such statements constitute summaries of documents or legal proceedings or refer to matters of law or legal conclusions, and those statements in the Final Memorandum that are
descriptions of contracts, agreements or other legal documents or of legal proceedings, or refer to statements of law or legal conclusions, as of the date of the Final Memorandum, and as of the date hereof, are accurate and complete in all material
respects. 
  
 20. The statements in the Final Memorandum under the
caption “Material United States federal income tax considerations” constitute an accurate and complete summary of the matters discussed therein in all material respects. 
  
 21. Except as described in the Purchase Agreement, no person has the right, pursuant to the terms of any contract, agreement
or other instrument described in the Final Memorandum or described in or filed as an exhibit to the Annual Report or otherwise known to us, to cause the Company to register under the Act any shares of Common Stock or shares of any other capital
stock or other equity interest in the Company or to include any such shares or interest in any registration statement to be filed with the Commission pursuant to the Registration Rights Agreement, whether as a result of the sale of the Notes as
contemplated in the Purchase Agreement or otherwise. 
  
 22.
Assuming the accuracy of the representations and warranties of the Company and the Initial Purchasers in the Purchase Agreement and that the Company and the Initial Purchasers comply with their respective covenants set forth in the Purchase
Agreement, no registration of the Notes or the Shares under the Act, and no qualification of the Indenture under the Trust Indenture Act, is required in connection with (a) the offer, sale and delivery of the Notes to the Initial Purchasers, or
(b) the initial resale of the Notes by the Initial Purchasers or (c) the conversion of the Notes into Shares, in each case in the manner contemplated by the Final Memorandum, the Purchase Agreement, the Indenture and the Notes. The Notes, when
issued, will not be of the same class 

  

 B-5 

 
(within the meaning of Rule 144A under the Act) as securities that are listed on a national securities exchange registered pursuant to Section 6 of the
Exchange Act or quoted in a U.S. automated inter-dealer quotation system. 
  
 23. To the best of our knowledge, neither the Company nor any Subsidiary (nor any agent thereof acting on their behalf) has taken any action that would cause the Purchase Agreement or the issuance or sale of the Notes
or the issuance of the Shares upon conversion of the Notes to violate Regulations T, U or X of the Board of Governors of the Federal Reserve System, in each case as in effect on the date hereof. 
  
 We have participated in conferences with officers and other representatives
of the Company, representatives of the independent public accountants of the Company and representatives of the Initial Purchasers at which the contents of the Final Memorandum were discussed and, although we are not passing upon and do not assume
responsibility for the accuracy, completeness or fairness of the statements contained in the Final Memorandum (except as and to the extent stated in subparagraphs 9, 11, 19 and 20 above), on the basis of the foregoing we can supplementally advise
you as a matter of fact and not as an opinion that nothing has come to our attention that causes us to believe that the Final Memorandum, as of its date or as of the date hereof, contained or contains an untrue statement of a material fact or
omitted or omits to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading (it being understood that we express no belief with respect
to the financial statements, notes to financial statements and schedules, and other financial or statistical data, included in the Final Memorandum). Our belief is based upon the procedures set forth above, but is without independent check or
verification. 
  
 We express no opinion with respect to:

  
 i. the effect of provisions releasing or
indemnifying a party against liability for its own wrongful or negligent acts, or where rights to indemnification and contribution are contrary to public policy or may be limited under applicable law; 
  
 ii. the enforceability of the choice of law provisions
contained in the Purchase Agreement, Registration Rights Agreement and the Indenture; 
  
 iii. the enforceability of the provisions in the Purchase Agreement, Registration Rights Agreement and Indenture selecting a particular
trial venue; 
  
 iv. the effect of California
Civil Code Section 1670.5, which provides that a court may refuse to enforce, or may limit the application of, a contract or any clause thereof which the court finds as a matter of law to have been unconscionable at the time it was made;

  
 v. the effect of California Civil Code
Section 1671 which provides in part that a contractual provision liquidating the damages for breach of contract in a commercial transaction will be invalid if it is established that the provision was “unreasonable” under the
circumstances existing at the time the contract was made; or 
  
 vi. the effect of Section 1698 of the California Civil Code which provides in part that provisions of any instrument or agreement may only be waived in writing will not be enforced to the extent that an oral
agreement has been executed modifying provisions of such instrument or agreement. 
  

 B-6 

 We are members of the Bar of the State of California and, accordingly, do not purport to be experts on or
to be qualified to express any opinion herein concerning, nor do we express any opinion herein concerning, any laws other than the laws of the State of California, the General Corporation Law of the State of Delaware and federal law of the United
States. We call your attention to the fact that the Purchase Agreement, the Registration Rights Agreement, the Indenture and the Notes state that they are governed by New York law and that we are not rendering any opinion with respect to New York
law. We have not examined the question of what law would govern the interpretation or enforcement of the Purchase Agreement, the Registration Rights Agreement, the Indenture or the Notes and our opinion is based on the assumption that the internal
laws of the State of California and federal law would govern the provisions of the Purchase Agreement, the Registration Rights Agreement, the Indenture and the Notes and the transactions contemplated thereby. 
  
 The foregoing opinions are being furnished to you solely for your benefit and
may not be relied upon by any other person, other than Willkie Farr & Gallagher LLP, as counsel for the Initial Purchasers, without our prior written consent. 
  

	
	 Very truly yours,

	
	STRADLING YOCCA CARLSON & RAUTH

  

 B-7 

 EXHIBIT C 
  
 FORM OF CERTIFICATE OF JAMES J. SULLIVAN 
  
 September     , 2005 
  
 UBS Securities LLC 
 Banc of America Securities LLC 
 William Blair & Company, L.L.C. 
 as Initial Purchasers 
 c/o UBS Securities LLC 
 299 Park Avenue 
 New York, New York 10171-0026 
  
 Ladies and Gentlemen: 
  
 I am the Senior Vice President and General Counsel to the TriZetto Group,
Inc., a Delaware corporation (the “Company”). You have requested that I issue this letter in connection with (i) the Offering Memorandum, dated September     , 2005 (the “Final Memorandum”), and
(ii) the Purchase Agreement, dated September     , 2005 (the “Purchase Agreement”), by and among the Company and UBS Securities LLC and Bank of America Securities (the “Initial Purchasers”),
pursuant to which (a) the Company has agreed to sell to the Initial Purchasers, and the Initial Purchasers have agreed to purchase from the Company,
$                     aggregate principal amount of its             %
Senior Convertible Notes due 2025 (the “Notes”) and (b) the Company granted an option to the Initial Purchasers to purchase up to an additional
$                     aggregate principal amount of the Notes. This letter is being delivered pursuant to Section 7(b) of the Purchase
Agreement. Unless specifically defined herein or the context requires otherwise, capitalized terms used herein shall have the meanings set forth in the Purchase Agreement. 
  
 Whenever a statement herein is qualified by “known to me,” “to my knowledge,” or similar phrase, it is
intended to indicate that no information that would give me current actual knowledge of the inaccuracy of such statement has come to my attention as of the date of this letter. I have not undertaken any independent investigation to determine the
accuracy of such statement, and any limited inquiry undertaken by me during the preparation of this letter should not be regarded as such an investigation; no inference as to my knowledge of any matters bearing on the accuracy of any such statement
should be drawn from the fact of my position with the Company. I have undertaken no duty to update any statement contained in this letter if any facts, circumstances or my knowledge as of the date of this letter changes at any time after the date of
this letter. 
  
 Based on the foregoing and subject to the
qualifications set forth herein, I hereby certify to the following: 
  

	 	1.	I am the Senior Vice President and General Counsel to the Company. 

  

 C-1 

	 	2.	To my knowledge and except as disclosed in the Final Memorandum or any Incorporated Document, (i) neither the Company nor any of the Subsidiaries is infringing, illegally using
or otherwise violating any patents, trade secrets, trademarks, service marks, copyrights or other proprietary information or materials of others, and (ii) there are no infringements or uses by others of any of the material trade secrets,
trademarks, service marks, copyrights, computer software, databases, Internet website domain names or other proprietary information or materials of the Company or any of the Subsidiaries which in my judgment would affect materially the use thereof
by the Company or any of the Subsidiaries, or the validity and enforceability of the proprietary rights of the Company or any of the Subsidiaries therein. 

  

	 	3.	Except as otherwise disclosed in the Final Memorandum or any Incorporated Document, I have no knowledge of any facts which would preclude the Company or any of the Subsidiaries from
having valid and enforceable license or other rights to use, or holding title free and clear of security interests, liens, encumbrances or claims of any nature to, the material trade secrets, trademarks, service marks, copyrights, computer software,
databases, Internet website domain names or other proprietary information and materials referenced in the Final Memorandum; and I have no knowledge that the Company or any of the Subsidiaries lacks or will be unable to obtain any rights or licenses
to use all proprietary information and materials that are necessary to conduct the business as now materially conducted by the Company or the Subsidiaries as described in the Final Memorandum or Incorporated Document incorporated by reference
therein, except as described in the Final Memorandum or any Incorporated Document. 

  
 I am not an expert in matters of intellectual property and I am not a member of the Patent Bar. The foregoing is being provided to you in my capacity as
Senior Vice President and General Counsel of the Company, and not in my individual capacity. 
  

	
	 Sincerely,

	
	  
 James J. Sullivan,

	Senior Vice President and General Counsel

  

 C-2 

 EXHIBIT D 
  
 OFFICERS’ CERTIFICATE 
  
 Each of the undersigned, Jeffrey H. Margolis, Chief Executive Officer of The TriZetto Group, Inc., a Delaware corporation (the
“Company”), and James C. Malone, Chief Financial Officer of the Company, on behalf of the Company, does hereby certify pursuant to Section 7(h) of that certain Purchase Agreement dated September     ,
2005 (the “Purchase Agreement”) among the Company and the Initial Purchaser named therein, that as of September     , 2005: 
  

	1.	He has reviewed the Final Memorandum. 

  

	2.	The representations and warranties of the Company as set forth in the Purchase Agreement are true and correct as of the date hereof and as if made on the date hereof.

  

	3.	The Company has performed all of its obligations under the Purchase Agreement as are to be performed at or before the date hereof. 

  

	4.	The conditions set forth in paragraphs (f) and (g) of Section 7 of the Purchase Agreement have been met. 

  

	5.	The financial statements and other financial information included or incorporated by reference in the Final Memorandum fairly present the financial condition, results of operations
and cash flows of the Company and the Subsidiaries as of, and for, the periods therein presented. 

  
 Capitalized terms used herein without definition shall have the respective meanings ascribed to them in the Purchase Agreement. 
  
 IN WITNESS WHEREOF, the
undersigned have hereunto set their hands on this September     , 2005. 
  

			
	  

	Name:	 	Jeffrey H. Margolis
	Title:	 	Chief Executive Officer
	  
  

	Name:	 	James C. Malone
	Title:	 	Chief Financial Officer

  

 D-1 

 EXHIBIT E 
  
 OFFICER’S CERTIFICATE 
  
 I, James C. Malone, Chief Financial Officer of The TriZetto Group, Inc., a Delaware corporation (the “Company”), hereby certify that:

  
 (i) I am familiar with the terms of (a) the Indenture
dated September     , 2005 between the Company and Wells Fargo Corporate Trust, as Trustee, relating to the Company’s             % Convertible Senior
Notes due 2025 and (b) any and all other agreements relating to the indebtedness of the Company and the Subsidiaries outstanding on the date hereof (each as may be amended as of the date hereof, collectively, and together with the previously
mentioned Indenture, the “Debt Agreements”). For the purpose of this certificate, I have reviewed in particular the covenants contained in the Debt Agreements, including those which require the maintenance of certain financial
ratios or similar requirements by the Company and/or which prohibit the incurring of debt by the Company under various circumstances, and the events of default provided for by the Debt Agreements. 
  
 (ii) On the date hereof, there exists no event of default or event which,
with notice or lapse of time or both, would constitute an event of default under the Debt Agreements. 
  
 (iii) Neither the issuance by the Company of up to $             aggregate principal
amount of the Notes pursuant to the Purchase Agreement (assuming exercise in full of the Initial Purchaser’s option to purchase up to $[            ] aggregate principal amount
of additional Notes), nor the issuance by the Company of Common Stock upon conversion of the Notes will result in an event of default or an event which, with notice or lapse of time or both, would constitute an event of default under the Debt
Agreements. 
  
 (iv) Without limiting the generality of the
foregoing, for the purposes of this certificate, I have made or caused to be made the computations set forth in Schedule A hereto as of [date of latest financial statements] of certain financial ratios under the Debt Agreements, which were
utilized in order to make the statements contained herein. The terms used in Schedule A hereto are defined in the Debt Agreements. 
  
 (v) I am sufficiently familiar with the financial affairs of the Company by reason of my present position with the Company to make the statements
contained in this certificate, which are based upon the audited consolidated financial statements of the Company and the Subsidiaries as of and for the year ended 2004, the unaudited financial statements of the Company and the Subsidiaries as of and
for the quarters ended March 31, 2005, June 30, 2005 and September 30, 2005, and other written statements, summaries, tabulations and computations, which I believe to be accurate, complete and reliable, made and furnished to me
by employees of the Company in the regular course of their duty. I am also sufficiently familiar with the present financial condition and operating results of the Company and the Subsidiaries that any material changes in the facts underlying the
data relied upon by me in making this certificate occurring since the respective dates of such data would have come to my attention prior to the date hereof in the regular course of business. 
  

 E-1 

 Capitalized terms used herein without definition shall have the respective meanings ascribed to them in
the Purchase Agreement. 
  
 IN
WITNESS WHEREOF, I have hereunto set my hand on this September     , 2005. 
  

			
	  

	Name:	 	James C. Malone
	Title:	 	Chief Financial Officer

  

 E-2Registration Rights Agreement

 EXHIBIT 4.2 
  

EXECUTION COPY 
  
 THE TRIZETTO GROUP, INC. 
  
 REGISTRATION RIGHTS AGREEMENT 
  
 October 5, 2005 

 REGISTRATION RIGHTS AGREEMENT 
  
 THIS REGISTRATION RIGHTS
AGREEMENT (the “Agreement”) is made and entered into as of October 5, 2005, by and among The TriZetto Group, Inc., a Delaware corporation (the “Company”), and UBS Securities LLC, Banc of America
Securities LLC and William Blair & Company, L.L.C. (the “Initial Purchasers”) pursuant to that certain Purchase Agreement, dated September 30, 2005 (the “Purchase Agreement”), among the Company and the
Initial Purchasers. 
  
 In order to induce the Initial Purchasers
to enter into the Purchase Agreement, the Company has agreed to provide the registration rights set forth in this Agreement. The execution of this Agreement is a condition to the closing under the Purchase Agreement. The terms “herein,”
“hereof,” “hereto,” “hereinafter” and similar terms, as used in this Agreement, shall in each case refer to this Agreement as a whole and not to any particular section, paragraph, sentence or other subdivision of this
Agreement. 
  
 The Company agrees with the Initial Purchasers
(i) for their benefit as Initial Purchasers and (ii) for the benefit of the beneficial owners (including the Initial Purchasers) from time to time of the Covered Securities (as defined herein) (each of the foregoing a
“Holder” and, together, the “Holders”), as follows: 
  
 1. Definitions. Capitalized terms used herein without definition shall have the respective meanings set forth in the Purchase Agreement. As used in this Agreement, the following terms shall have the following
meanings: 
  
 (a) “Additional Filing
Deadline Date” has the meaning set forth in Section 2(d) hereof. 
  
 (b) “additional interest” has the meaning set forth in Section 2(d) hereof. 
  
 (c) “Additional Interest Accrual Period”
has the meaning set forth in Section 2(d) hereof. 
  
 (d) “Additional Interest Amount” has the meaning set forth in Section 2(d) hereof. 
  
 (e) “Additional Interest Payment Date” means each April 1 and October 1 of each year. 
  
 (f) “Affiliate” means, with respect to any
specified person, an “affiliate,” as defined in Rule 144, of such person. 
  
 (g) “Amendment Effectiveness Deadline Date” has the meaning set forth in Section 2(d) hereof. 
  

 - 1 - 

 (h) “Business Day” means each day on which the NASDAQ is open for
trading. 
  
 (i) “Claim” has the
meaning set forth in Section 9(o) hereof. 
  
 (j) “Common Stock” means the shares of common stock, $0.001 par value per share, of the Company and any other shares of capital stock as may constitute “Common Stock” for purposes of the Indenture, including the
Underlying Common Stock. 
  
 (k)
“Conversion Rate” has the meaning ascribed to it in the Indenture. 
  
 (l) “Covered Security” has the meaning set forth in Section 1(tt) hereof. 
  
 (m) “Effectiveness Deadline Date” has the
meaning set forth in Section 2(a) hereof. 
  
 (n) “Effectiveness Period” means a period (subject to extension pursuant to Section 3(i) hereof) that terminates when there are no Registrable Securities outstanding. 
  
 (o) “Event” has the meaning set forth in
Section 2(d) hereof. 
  
 (p) “Event
Date” has the meaning set forth in Section 2(d) hereof. 
  
 (q) “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder. 
  
 (r) “Filing Deadline Date” has the meaning
set forth in Section 2(a) hereof. 
  
 (s)
“Form S-1” means Form S-1 under the Securities Act. 
  
 (t) “Form S-3” means Form S-3 under the Securities Act. 
  
 (u) “Fundamental Change Repurchase Date” has the meaning ascribed to it in the Indenture. 
  
 (v) “Holder” has the meaning set forth in
the preamble hereto. 
  
 (w) “Holder
Information” has the meaning set forth in Section 6(b) hereof. 
  
 (x) “Indemnified Party” has the meaning set forth in Section 6(c) hereof. 
  
 (y) “Indemnifying Party” has the meaning set forth in Section 6(c) hereof. 
  
 (z) “Indenture” means the Indenture, dated
as of October 5, 2005, between the Company and the Trustee, pursuant to which the Notes are being issued. 
  

 - 2 - 

 (aa) “Initial Purchasers” has the meaning set forth in the preamble
hereto. 
  
 (bb) “Initial Shelf
Registration Statement” has the meaning set forth in Section 2(a) hereof. 
  
 (cc) “Issue Date” means October 5, 2005. 
  
 (dd) “Make-Whole Premium” has the meaning ascribed to it in the Indenture. 
  
 (ee) “Managing Underwriters” has the
meaning set forth in Section 8(a) hereof. 
  
 (ff) “Material Event” has the meaning set forth in Section 3(i) hereof. 
  
 (gg) “NASD Rules” has the meaning set forth in Section 3(s) hereof. 
  
 (hh) “Notes” means the 2.75% Convertible
Senior Notes due 2025 of the Company to be purchased pursuant to the Purchase Agreement. 
  
 (ii) “Notice and Questionnaire” means a written questionnaire containing substantially the information called for by the
Selling Securityholder Notice and Questionnaire attached as Annex A to the Offering Memorandum of the Company, dated September 30, 2005, relating to the Notes. 
  
 (jj) “Notice Holder” means, on a given date, any Holder that has delivered a Notice and
Questionnaire to the Company on or prior to such date, provided not all of such Holder’s Registrable Securities that have been registered for resale pursuant to a Notice and Questionnaire have been sold in accordance with a Shelf Registration
Statement. 
  
 (kk) “Option Purchase
Date” has the meaning ascribed to it in the Indenture. 
  
 (ll) “Proceeding” has the meaning set forth in Section 6(c) hereof. 
  
 (mm) “Prospectus” means the prospectus included in any Shelf Registration Statement (including, without limitation, a
prospectus that discloses information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 415 under the Securities Act), as amended or supplemented by any amendment or prospectus
supplement, including post-effective amendments and any prospectus filed with respect to any Shelf Registration Statement pursuant to Rule 424 under the Securities Act, and all materials incorporated by reference or deemed to be incorporated by
reference in such Prospectus. 
  
 (nn)
“Purchase Agreement” has the meaning set forth in the preamble hereof. 
  

 - 3 - 

 (oo) “Purchase at Holder’s Option” has the meaning ascribed to it
in the Indenture. 
  
 (pp) “Record
Date” means, (i) September 15, with respect to an Additional Interest Payment Date that occurs on October 1 and (ii) March 15, with respect to an Additional Interest Payment Date that occurs on April 1.

  
 (qq) “Record Holder” means,
with respect to an Additional Interest Payment Date relating to a Registrable Security for which any Additional Interest Amount has accrued, a Notice Holder that was the holder of record of such Registrable Security at the close of business on the
Record Date relating to such Additional Interest Payment Date. 
  
 (rr) “Redemption” has the meaning ascribed to it in the Indenture. 
  
 (ss) “Redemption Date” has the meaning ascribed to it in the Indenture. 
  
 (tt) “Registrable Securities” means the
Notes, until such Notes have been converted into the Underlying Common Stock, and, at all times, the Underlying Common Stock and any securities into or for which such Underlying Common Stock has been converted or exchanged, and any security issued
with respect thereto upon any stock dividend, split or similar event (each of the foregoing, a “Covered Security”) until, in the case of any such security, the earliest of: 
  
 (i) the date on which such security has been effectively
registered under the Securities Act and disposed of in accordance with the Registration Statement relating thereto; 
  
 (ii) the date on which such security may be resold without restriction pursuant to Rule 144(k) or any successor provision thereto; or

  
 (iii) the date on which such security has
been publicly sold pursuant to Rule 144 or any successor provision thereto. 
  
 (uu) “Registration Expenses” has the meaning set forth in Section 5 hereof. 
  
 (vv) “Registration Statement” means any registration statement, under the Securities Act, of the Company that covers any
of the Registrable Securities pursuant to this Agreement, including the Prospectus, amendments and supplements to such registration statement, including post-effective amendments, all exhibits and all materials incorporated by reference or deemed to
be incorporated by reference in such registration statement, Prospectus, amendment or supplement. 
  
 (ww) “Repurchase Upon Fundamental Change” has the meaning ascribed to it in the Indenture. 
  
 (xx) “Rule 144” means Rule 144 under the
Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC. 
  

 - 4 - 

 (yy) “Rule 144A” means Rule 144A under the Securities Act, as such Rule
may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC. 
  
 (zz) “SEC” means the Securities and Exchange Commission. 
  
 (aaa) “Securities Act” means the Securities Act of 1933, as amended, and the rules and
regulations promulgated by the SEC thereunder. 
  
 (bbb) “Shelf Registration Statement” means the Initial Shelf Registration Statement and any Subsequent Shelf Registration Statement. 
  

(ccc) “Subsequent Shelf Registration Statement” has the meaning set forth in Section 2(b) hereof. 
  
 (ddd) “Subsequent Shelf Registration Statement
Effectiveness Deadline Date” has the meaning set forth in Section 2(d) hereof. 
  
 (eee) “Suspension Notice” has the meaning set forth in Section 3(i) hereof. 
  
 (fff) “Suspension Period” has the meaning
set forth in Section 3(i) hereof. 
  
 (ggg)
“TIA” means the Trust Indenture Act of 1939, as amended. 
  
 (hhh) “Trustee” means Wells Fargo Corporate Trust, the trustee under the Indenture. 
  
 (iii) “Underlying Common Stock” means the Common Stock issuable upon conversion of the Notes or upon payment of any
Make-Whole Premium. 
  
 2. Shelf Registration. 

 
 (a) The Company shall prepare and file, or cause to be
prepared and filed, with the SEC, as soon as practicable but in any event by the date (the “Filing Deadline Date”) that is ninety (90) days after the Issue Date, a Registration Statement (the “Initial Shelf Registration
Statement”) for an offering to be made on a delayed or continuous basis pursuant to Rule 415 under the Securities Act registering the resale from time to time by Holders thereof of all of the Registrable Securities (or, if registration of
Registrable Securities not held by Notice Holders is not permitted by the rules and regulations of the SEC, then registering the resale from time to time by Notice Holders of their Registrable Securities). The Initial Shelf Registration Statement
shall be on Form S-1 or Form S-3 or another appropriate form and shall provide for the registration of such Registrable Securities for resale by such Holders in accordance with any reasonable 

  

 - 5 - 

 
method of distribution elected by the Holders. The Company shall use its best efforts to (i) cause the Initial Shelf Registration Statement to become
effective under the Securities Act as promptly as practicable but in any event by the date (the “Effectiveness Deadline Date”) that is one hundred eighty (180) days after the Issue Date and (ii) keep the Initial Shelf
Registration Statement (or any Subsequent Shelf Registration Statement) continuously effective under the Securities Act until the expiration of the Effectiveness Period. At the time the Initial Shelf Registration Statement becomes effective under
the Securities Act, each Holder that became a Notice Holder prior to the date of such effectiveness shall be named as a selling securityholder in the Initial Shelf Registration Statement and the related Prospectus in such a manner as to permit such
Holder to deliver such Prospectus to purchasers of Registrable Securities in accordance with applicable law. 
  
 (b) If any Shelf Registration Statement ceases to be effective under the Securities Act for any reason at any time during the
Effectiveness Period, the Company shall use its best efforts to promptly cause such Shelf Registration Statement to become effective under the Securities Act (including obtaining the prompt withdrawal of any order suspending the effectiveness of
such Shelf Registration Statement), and in any event if permissible under the Securities Act and the rules and regulations thereunder, shall, within thirty (30) days of such cessation of effectiveness, (i) amend such Shelf Registration
Statement in a manner reasonably expected to obtain the withdrawal of any order suspending the effectiveness of such Shelf Registration Statement or (ii) file an additional Registration Statement (a “Subsequent Shelf Registration
Statement”) for an offering to be made on a delayed or continuous basis pursuant to Rule 415 of the Securities Act registering the resale from time to time by Holders thereof of all securities that are Registrable Securities as of the time
of such filing (or, if registration of Registrable Securities not held by Notice Holders is not permitted by the rules and regulations of the SEC, then registering the resale from time to time by Notice Holders of their securities that are
Registrable Securities as of the time of such filing). If a Subsequent Shelf Registration Statement is filed, the Company shall use its best efforts to (A) cause such Subsequent Shelf Registration Statement to become effective under the
Securities Act as promptly as practicable after such filing, but in no event later than the Subsequent Shelf Registration Statement Effectiveness Deadline Date and (B) keep such Subsequent Shelf Registration Statement (or another Subsequent
Shelf Registration Statement) continuously effective until the end of the Effectiveness Period. Any such Subsequent Shelf Registration Statement shall be on Form S-1 or Form S-3 or another appropriate form and shall provide for the registration of
such Registrable Securities for resale by such Holders in accordance with any reasonable method of distribution elected by the Holders. 
  
 (c) The Company shall supplement and amend any Shelf Registration Statement if required by the rules, regulations or instructions
applicable to the registration form used by the Company for such Shelf Registration Statement, if required by the Securities Act or as reasonably requested by the Initial Purchasers or by the Trustee on behalf of the Holders of the Registrable
Securities covered by such Shelf Registration Statement. 
  

 - 6 - 

 (i) Each Holder of Registrable Securities agrees that, if such Holder wishes to sell
Registrable Securities pursuant to a Shelf Registration Statement and related Prospectus, it will do so only in accordance with this Section 2(d) and Section 3(i). Each Holder of Registrable Securities wishing to sell Registrable Securities
pursuant to a Shelf Registration Statement and related Prospectus agrees to deliver a completed and executed Notice and Questionnaire to the Company at least five (5) Business Days prior to any attempted or actual distribution of Registrable
Securities under a Shelf Registration Statement. If a Holder becomes a Notice Holder on or after the date the Initial Shelf Registration Statement becomes effective under the Securities Act, the Company shall, as promptly as practicable after the
date such Holder became a Notice Holder, and in any event, subject to clause (B) below, within the later of (x) five (5) Business Days after such date or (y) five (5) Business Days after the expiration of any Suspension
Period that either (I) is in effect when such Holder became a Notice Holder or (II) is put into effect within five (5) Business Days after the date such Holder became a Notice Holder, 
  
 (A) if required by applicable law, file with the SEC a
supplement to the related Prospectus or a post-effective amendment to the Shelf Registration Statement or file with the SEC a Subsequent Shelf Registration Statement and any necessary supplement or amendment to any document incorporated therein by
reference and file any other required document with the SEC so that such Notice Holder is named as a selling securityholder in a Shelf Registration Statement and the related Prospectus in such a manner as to permit such Notice Holder to deliver a
Prospectus to purchasers of the Registrable Securities in accordance with applicable law; provided, however, the Company shall not be required to file more than one (1) supplement, post-effective amendment or Subsequent Shelf
Registration Statement for such purpose in any thirty (30) day period; 
  
 (B) if, pursuant to Section 2(c)(i)(A), the Company shall have filed a post-effective amendment to the Shelf Registration Statement or filed a Subsequent Shelf Registration Statement, the Company shall use its
best efforts to cause such post-effective amendment or Subsequent Shelf Registration Statement, as the case may be, to become effective under the Securities Act as promptly as practicable, but in any event by the date (the “Amendment
Effectiveness Deadline Date,” in the case of a post-effective amendment, and the “Subsequent Shelf Registration Statement Effectiveness Deadline Date,” in the case of a Subsequent Shelf Registration Statement) that is
thirty (30) days after the date such post-effective amendment or Subsequent Shelf Registration Statement, as the case may be, is required by this Section 2(d) to be filed with the SEC; 
  

 - 7 - 

 (C) the Company shall provide such Notice Holder a reasonable number of copies of any
documents filed pursuant to clause (A) above; 
  
 (D) the Company shall notify such Notice Holder as promptly as practicable after the effectiveness under the Securities Act of any post-effective amendment or Subsequent Shelf Registration Statement filed pursuant to clause (A) above;

  
 (E) if such Holder became a Notice Holder
during a Suspension Period, or a Suspension Period is put into effect within five (5) Business Days after the date such Holder became a Notice Holder, the Company shall so inform such Notice Holder and shall take the actions set forth in
clauses (A), (B), (C) and (D) above within five (5) Business Days after expiration of such Suspension Period in accordance with Section 3(i); and 
  
 (F) if, under applicable law, the Company has more than one option as to the type or manner of making any
such filing, the Company shall make the required filing or filings in the manner or of a type that is reasonably expected to result in the earliest availability of a Prospectus for effecting resales of Registrable Securities. 
  
 (ii) Notwithstanding anything contained herein to the
contrary, the Company shall be under no obligation to name any Holder that is not a Notice Holder as a selling securityholder in any Shelf Registration Statement or related Prospectus; provided, however, that any Holder that becomes a
Notice Holder (regardless of when such Holder became a Notice Holder) shall be named as a selling securityholder in a Shelf Registration Statement or related Prospectus in accordance with the requirements of this Section 2(d) or Section 2(a),
as applicable. 
  
 (d) The parties hereto agree
that the Holders of Registrable Securities will suffer damages, and that it would not be feasible to ascertain the extent of such damages with precision, if: 
  

(i) the Initial Shelf Registration Statement has not been filed with the SEC on or prior to the Filing Deadline Date; 
  
 (ii) the Initial Shelf Registration Statement has not become
effective under the Securities Act on or prior to the Effectiveness Deadline Date; 
  
 (iii) either a supplement to a Prospectus, a post-effective amendment or a Subsequent Shelf Registration Statement is required to be filed
with the SEC and fails to be filed with the SEC within the prescribed period and in the manner set forth in Section             (the date such filing is 

  

 - 8 - 

 
required to be made being an “Additional Filing Deadline Date”) or, in the case of a post-effective amendment or a Subsequent Shelf
Registration Statement, such post-effective amendment or Subsequent Registration Statement does not become effective under the Securities Act by the Amendment Effectiveness Deadline Date or the Subsequent Shelf Registration Statement Effectiveness
Deadline Date, as the case may be; 
  
 (iv) the
Initial Shelf Registration Statement or any Subsequent Registration Statement is filed with the SEC and becomes effective under the Securities Act but shall thereafter cease to be effective (without being succeeded immediately by a new Registration
Statement that is filed and immediately becomes effective under the Securities Act) or usable for the offer and sale of Registrable Securities in the manner contemplated by this Agreement for a period of time (including any Suspension Period) which
shall exceed thirty (30) days in the aggregate in any three (3) month period or sixty (60) days in the aggregate in any twelve (12) month period; or 
  
 (v) any Registration Statement or amendment thereto, at the time it becomes effective under the Securities
Act, or any Prospectus relating thereto, at the time it is filed with the SEC or, if later, at the time the Registration Statement to which such Prospectus relates becomes effective under the Securities Act, shall fail to name each Holder as a
selling securityholder in such a manner as to permit such Holder to sell its Registrable Securities pursuant to such Registration Statement and Prospectus in accordance with applicable law, which Holder was entitled, pursuant to the terms of this
Agreement, to be so named (it being understood that, without limitation, naming such Holder in a manner that permits such Holder to sell only a portion of such Holder’s Registrable Securities referenced in such Holder’s Notice and
Questionnaire shall be deemed to be an “Event” (as defined below) for purposes of this clause (v)). 
  
 Each of the events of a type described in any of the foregoing clauses (i) through (v) are individually referred to herein as an
“Event,” and 
  
 (V) the Filing
Deadline Date, in the case of clause (i) above, 
  
 (W) the Effectiveness Deadline Date, in the case of clause (ii) above, 
  
 (X) the Additional Filing Deadline Date, the Amendment Effectiveness Deadline Date or the Subsequent Shelf Registration Statement
Effectiveness Deadline Date, as the case may be, in the case of clause (iii) above, 
  
 (Y) the date on which the duration of the ineffectiveness or unusability of the Shelf Registration Statement exceeds the number of days
permitted by clause (iv) above, in the case of clause (iv) above, and 
  
 (Z) the date the applicable Registration Statement or amendment 

  

 - 9 - 

 
thereto shall become effective under the Securities Act, or the date the applicable Prospectus is filed with the SEC or, if later, the time the Registration
Statement to which such Prospectus relates becomes effective under the Securities Act, as the case may be, in the case of clause (v) above, 
  
 are each herein referred to as an “Event Date.” Events shall be deemed to continue until the following dates with respect to the
respective types of Events: 
  
 (A) the date the
Initial Shelf Registration Statement is filed with the SEC, in the case of an Event of the type described in clause (i) above; 
  
 (B) the date the Initial Shelf Registration Statement becomes effective under the Securities Act, in the case of an Event of the type
described in clause (ii) above; 
  
 (C) the
date a supplement to a Prospectus, a post-effective amendment or a Subsequent Shelf Registration Statement, whichever is required, is filed with the SEC (in the case of a supplement) or becomes effective under the Securities Act (in the case of a
post-effective amendment or a Subsequent Shelf Registration Statement), in the case of an Event of the type described in clause (iii) above; 
  
 (D) the date the Initial Shelf Registration Statement or the Subsequent Shelf Registration Statement, as the case may be, becomes
effective and usable again, or the date another Subsequent Shelf Registration Statement is filed with the SEC pursuant to Section 2(b) and becomes effective, in the case of an Event of the type described in clause (iv) above; or

  
 (E) the date a supplement to the Prospectus
is filed with the SEC, or the date a post-effective amendment to the Registration Statement becomes effective under the Securities Act, or the date a Subsequent Shelf Registration Statement becomes effective under the Securities Act, which
supplement, post-effective amendment or Subsequent Shelf Registration Statement, as the case may be, names as selling securityholders, in such a manner as to permit them to sell their Registrable Securities pursuant to the Registration Statement and
Prospectus supplement in accordance with applicable law, all Holders entitled as herein provided to be so named, in the case of an Event of the type described in clause (v) above. 
  
 Accordingly, commencing on (and including) any Event Date and ending on (but excluding) the next date on which there are no
Events that have occurred and are continuing (an “Additional Interest Accrual Period”), the Company agrees to pay, as additional interest (“additional interest”) and not as a penalty, an amount (the
“Additional Interest Amount”) at the rate described below, payable periodically on each Additional Interest Payment Date to Record Holders, to the extent of, for each such Additional Interest Payment Date, the unpaid Additional
Interest Amount that has accrued to (but excluding) such Additional Interest Payment Date (or, if the Additional Interest Accrual 

  

 - 10 - 

 
Period shall have ended prior to such Additional Interest Payment Date, the day immediately after the last day of such Additional Interest Accrual Period);
provided, however, that any unpaid Additional Interest Amount that has accrued with respect to any Note, or portion thereof, called for Redemption on a Redemption Date, or purchased by the Company pursuant to a Purchase at
Holder’s Option or Repurchase Upon Fundamental Change on an Option Purchase Date or Fundamental Change Repurchase Date, as the case may be, that is after the close of business on the Record Date relating to such Additional Interest Payment Date
and before such Additional Interest Payment Date, shall, in each case, be instead paid, on such Redemption Date, Option Purchase Date or Fundamental Change Repurchase Date, as the case may be, to the Holder who submitted such Note or portion thereof
for Redemption, Purchase at Holder’s Option or Repurchase Upon Fundamental Change, as the case may be. 
  
 The Additional Interest Amount shall accrue at a rate per annum equal to one quarter of one percent (0.25%) for the ninety (90) day period beginning
on, and including, the Event Date and thereafter at a rate per annum equal to one half of one percent (0.50%) of the aggregate principal amount of the Notes of which such Record Holders were holders of record at the close of business on the
applicable Record Date; provided, however, that: 
  
 (I) unless there shall be a default in the payment of any Additional Interest Amount, no Additional Interest Amounts shall accrue as to any Note from and after the earlier of (x) the date such Note is no longer a
Registrable Security, (y) the date, and to the extent, such Note is converted into cash and, if applicable, shares of Common Stock in accordance with the Indenture and (z) the expiration of the Effectiveness Period; 
  
 (II) only those Holders (or their subsequent transferees)
failing to be named as selling securityholders in the manner prescribed in Section 2(d)(v) above shall be entitled to receive any Additional Interest Amounts that have accrued solely with respect to an Event of the type described in
Section 2(d)(v) above (it being understood that this clause (II) shall not impair any right of any Holder to receive Additional Interest Amounts that have accrued with respect to an Event other than an Event of the type described in
Section 2(d)(v) above); 
  
 (III) only those
Holders (or their subsequent transferees) whose delivery of a Notice and Questionnaire gave rise to the obligation of the Company, pursuant to Section 2(c)(i), to file and, if applicable, make effective under the Securities Act the supplement,
post-effective amendment or Subsequent Shelf Registration Statement referred to in Section 2(d)(iii) above shall be entitled to receive any Additional Interest Amounts that have accrued solely with respect to an Event of the type described in
Section 2(d)(iii) above (it being understood that this clause (III) shall not impair any right of any Holder to receive Additional Interest Amounts that have accrued with respect to an Event other than an Event of the type described in
Section 2(d)(iii) above); and 
  
 (IV) if a
Note ceases to be outstanding during an Additional Interest 

  

 - 11 - 

 
Accrual Period for which an Additional Interest Amount would be payable with respect to such Note, then the Additional Interest Amount payable hereunder with
respect to such Note shall be prorated on the basis of the number of full days such Note is outstanding during such Additional Interest Accrual Period. 
  
 Except as provided in the final paragraph of this Section 2(d), (i) the rate of accrual of the Additional Interest Amount with respect to any
period shall not exceed the rate provided for in this Section 2(d) notwithstanding the occurrence of multiple concurrent Events and (ii) following the cure of all Events requiring the payment by the Company of Additional Interest Amounts
to the Holders pursuant to this Section, the accrual of Additional Interest Amounts shall cease (without in any way limiting the effect of any subsequent Event requiring the payment of Additional Interest Amounts by the Company). All installments of
additional interest shall be paid by wire transfer of immediately available funds to the account specified by the Notice Holder or, if no such account is specified, by mailing a check to such Notice Holder’s address shown in the register of the
registrar for the Notes or for the Underlying Common Stock, as the case may be. 
  
 All of the Company’s obligations set forth in this Section 2(d) that are outstanding with respect to any Registrable Security at the time such Registrable Security ceases to be a Registrable Security shall
survive until such time as all such obligations with respect to such security have been satisfied in full (notwithstanding termination of this Agreement pursuant to Section 9(n)). 
  
 The parties hereto agree that the additional interest provided for in this Section 2(d) constitutes a reasonable
estimate of the damages in respect of the Notes that may be incurred by Holders of the Notes by reason of an Event relating to such Notes, including, without limitation, the failure of a Shelf Registration Statement to be filed, become effective
under the Securities Act, amended or replaced to include the names of all Notice Holders or available for effecting resales of Registrable Securities in accordance with the provisions hereof. 
  
 If any Additional Interest Amounts are not paid when due, then, to the
extent permitted by law, such overdue Additional Interest Amounts, if any, shall bear interest, compounded semi-annually, until paid at the rate of interest payable with respect to overdue amounts on the Notes pursuant to Section 2.12 of the
Indenture. 
  
 (e) The Trustee shall be entitled,
on behalf of Holders, to seek any available remedy for the enforcement of this Agreement, including for the payment of any Additional Interest Amount. 
  
 3. Registration Procedures. In connection with the registration obligations of the Company under Section 2 hereof, the Company shall:

  
 (a) Prepare and file with the SEC a Shelf
Registration Statement or Shelf Registration Statements on Form S-1 or Form S-3 or any other appropriate form under the Securities Act available for the sale of the Registrable Securities by the Holders 

  

 - 12 - 

 
thereof in accordance with the intended method or methods of distribution thereof, and use its best efforts to cause each such Shelf Registration Statement
to become effective under the Securities Act and remain effective under the Securities Act as provided herein; provided, that, before filing any Shelf Registration Statement or Prospectus or any amendments or supplements thereto with the SEC,
the Company shall furnish to the Initial Purchasers and counsel for the Holders and for the Initial Purchasers (or, if applicable, separate counsel for the Holders) copies of all such documents proposed to be filed and reflect in each such document
when so filed with the SEC such comments as the Initial Purchasers or such counsel reasonably shall propose within three (3) Business Days of the delivery of such copies to the Initial Purchasers and such counsel. 
  
 (b) Prepare and file with the SEC such amendments and
post-effective amendments to each Shelf Registration Statement as may be necessary to keep such Shelf Registration Statement or Subsequent Shelf Registration Statement continuously effective until the expiration of the Effectiveness Period; cause
the related Prospectus to be supplemented by any required Prospectus supplement and, as so supplemented, to be filed with the SEC pursuant to Rule 424 (or any similar provisions then in force) under the Securities Act; and comply with the provisions
of the Securities Act applicable to it with respect to the disposition of all securities covered by each Shelf Registration Statement during the Effectiveness Period in accordance with the intended methods of disposition by the sellers thereof set
forth in such Shelf Registration Statement as so amended or such Prospectus as so supplemented. 
  
 (c) As promptly as practicable, give notice to the Notice Holders, the Initial Purchasers and counsel for the Holders and for the Initial
Purchasers (or, if applicable, separate counsel for the Holders): 
  
 (i) when any Prospectus, Prospectus supplement, Shelf Registration Statement or post-effective amendment to a Shelf Registration Statement has been filed with the SEC and, with respect to a Shelf Registration
Statement or any post-effective amendment, when the same has become effective under the Securities Act, 
  
 (ii) of any request, following the effectiveness of a Shelf Registration Statement under the Securities Act, by the SEC or any other
governmental authority for amendments or supplements to such Shelf Registration Statement or the related Prospectus or for additional information, 
  
 (iii) of the issuance by the SEC or any other governmental authority of any stop order suspending the effectiveness of any Shelf
Registration Statement or the initiation or threatening of any proceedings for that purpose, 
  
 (iv) of the receipt by the Company or its legal counsel of any notification with respect to the suspension of the qualification or
exemption from qualification of any of the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose, 
  

 - 13 - 

 (v) after the effective date of any Shelf Registration Statement filed with the SEC
pursuant to this Agreement, of the occurrence of (but not the nature of or details concerning) a Material Event, and 
  
 (vi) of the determination by the Company that a post-effective amendment to a Shelf Registration Statement or a Subsequent Shelf
Registration Statement will be filed with the SEC, which notice may, at the discretion of the Company (or as required pursuant to Section 3(i)), state that it constitutes a Suspension Notice, in which event the provisions of Section 3(i)
shall apply. 
  
 (d) Use its best efforts to
(i) prevent the issuance of, and, if issued, to obtain the withdrawal of, any order suspending the effectiveness of a Shelf Registration Statement and (ii) obtain the lifting of any suspension of the qualification (or exemption from
qualification) of any of the Registrable Securities for sale in any jurisdiction in which they have been qualified for sale, in either case at the earliest possible moment, and provide prompt notice to each Notice Holder and the Initial Purchasers,
and counsel for the Holders and for the Initial Purchasers (or, if applicable, separate counsel for the Holders), of the withdrawal or lifting of any such order or suspension. 
  
 (e) If requested by the Initial Purchasers or any Notice Holder, as promptly as practicable incorporate in a
Prospectus supplement or a post-effective amendment to a Shelf Registration Statement such information as the Initial Purchasers, such Notice Holder or counsel for the Holders and for the Initial Purchasers (or, if applicable, separate counsel for
the Holders) shall determine to be required to be included therein by applicable law and make any required filings of such Prospectus supplement or such post-effective amendment; provided, however, that the Company shall not be
required to take any actions under this Section 3(e) that, in the written opinion of counsel for the Company, are not in compliance with applicable law. 
  

(f) As promptly as practicable, furnish to each Notice Holder, counsel for the Holders and for the Initial Purchasers (or, if
applicable, separate counsel for the Holders) and the Initial Purchasers, without charge, at least one (1) conformed copy of each Shelf Registration Statement and each amendment thereto, including financial statements but excluding schedules,
all documents incorporated or deemed to be incorporated therein by reference and all exhibits (unless requested in writing to the Company by such Notice Holder, such counsel or the Initial Purchasers). 
  
 (g) During the Effectiveness Period, deliver to each Notice
Holder, counsel for the Holders and for the Initial Purchasers (or, if applicable, separate counsel for the Holders) and the Initial Purchasers, in connection with any sale of Registrable Securities pursuant to a Shelf Registration Statement,
without charge, as many copies of the Prospectus or Prospectuses relating to such Registrable Securities (including each preliminary prospectus) and any amendment or supplement thereto as such Notice Holder or the Initial Purchasers may reasonably
request; and the Company hereby consents (except during such periods that a Suspension Notice is outstanding and has not been 

  

 - 14 - 

 
revoked) to the use of such Prospectus and each amendment or supplement thereto by each Notice Holder, in connection with any offering and sale of the
Registrable Securities covered by such Prospectus or any amendment or supplement thereto in the manner set forth therein. 
  
 (h) Prior to any public offering of the Registrable Securities pursuant to a Shelf Registration Statement, use its best efforts to
register or qualify or cooperate with the Notice Holders in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable Securities for offer and sale under the securities or Blue Sky
laws of such jurisdictions within the United States as any Notice Holder reasonably requests in writing (which request may be included in the Notice and Questionnaire); use its best efforts to keep each such registration or qualification (or
exemption therefrom) effective during the Effectiveness Period in connection with such Notice Holder’s offer and sale of Registrable Securities pursuant to such registration or qualification (or exemption therefrom) and do any and all other
acts or things reasonably necessary or advisable to enable the disposition in such jurisdictions of such Registrable Securities in the manner set forth in the relevant Shelf Registration Statement and the related Prospectus; provided,
however, that the Company will not be required to (i) qualify generally to do business in any jurisdiction where it is not then so qualified (ii) take any action that would subject it to general service of process in suits, other
than those arising out of the offering or sale of Registrable Securities or arising in connection with this Agreement, in any jurisdiction where it is not now so subject; or (iii) take any action that would subject it to taxation in any
jurisdiction where it is not then so subject. 
  
 (i) Upon: (A) the occurrence or existence of any pending corporate development (a “Material Event”) that, in the reasonable discretion of the Company, makes it appropriate to suspend the availability of any Shelf
Registration Statement and the related Prospectus; (B) the issuance by the SEC of a stop order suspending the effectiveness of any Shelf Registration Statement or the initiation of proceedings with respect to any Shelf Registration Statement
under Section 8(d) or 8(e) of the Securities Act; or (C) the occurrence of any event or the existence of any fact as a result of which any Shelf Registration Statement shall contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary to make the statements therein not misleading, or any Prospectus shall contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading, 
  
 (i) in the case of clause (A) or (C) above, subject to the next sentence, as promptly as practicable, prepare and file, if
necessary pursuant to applicable law, a post-effective amendment to such Shelf Registration Statement or a supplement to such Prospectus or any document incorporated therein by reference or file any other required document that would be incorporated
by reference into such Shelf Registration Statement and Prospectus so that such Shelf Registration Statement does not contain any untrue statement of a material fact or omit to state 

  

 - 15 - 

 
any material fact required to be stated therein or necessary to make the statements therein not misleading, and so that such Prospectus does not contain any
untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, as thereafter delivered to the purchasers of the
Registrable Securities being sold thereunder, and, in the case of a post-effective amendment to a Shelf Registration Statement, subject to the next sentence, use its best efforts to cause it to become effective under the Securities Act as promptly
as practicable, and 
  
 (ii) give notice to the
Notice Holders and counsel for the Holders and for the Initial Purchasers (or, if applicable, separate counsel for the Holders) and to the Initial Purchasers that the availability of the Shelf Registration Statement is suspended (a
“Suspension Notice”) (and, upon receipt of any Suspension Notice, each Notice Holder agrees not to sell any Registrable Securities pursuant to such Shelf Registration Statement until such Notice Holder’s receipt of copies of
the supplemented or amended Prospectus provided for in clause (i) above or until such Notice Holder is advised in writing by the Company that the Prospectus may be used). 
  
 The Company will use its best efforts to ensure that the use of the Prospectus may be resumed (x) in the case of clause
(A) above, as soon as, in the reasonable discretion of the Company, such suspension is no longer appropriate, (y) in the case of clause (B) above, as promptly as is practicable, and (z) in the case of clause (C) above, as
soon as, in the reasonable judgment of the Company, the Shelf Registration Statement does not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein not misleading and the Prospectus does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The period during which the availability of the Shelf Registration Statement and any Prospectus may be suspended (the “Suspension Period”) without the Company incurring any obligation to pay additional interest
pursuant to Section 2(d) shall not exceed thirty (30) days in the aggregate in any three (3) month period or sixty (60) days in the aggregate in any twelve (12) month period. The Effectiveness Period shall be extended by the
number of days from and including the date of the giving of the Suspension Notice to and including the date on which the Notice Holder received copies of the supplemented or amended Prospectus provided in clause (i) above, or the date on which
it is advised in writing by the Company that the Prospectus may be used and has received copies of any additional or supplemental filings that are incorporated or deemed incorporated by reference in such Prospectus. 
  
 (j) Make available for inspection during normal business
hours by representatives for the Notice Holders and any underwriters participating in any disposition pursuant to any Shelf Registration Statement and any broker-dealers, attorneys and accountants retained by such Notice Holders or any such
underwriters, all 

  

 - 16 - 

 
relevant financial and other records and pertinent corporate documents and properties of the Company and its subsidiaries, and cause the appropriate
officers, directors and employees of the Company and its subsidiaries to make available for inspection during normal business hours all relevant information reasonably requested by such representatives for the Notice Holders, or any such
underwriters, broker-dealers, attorneys or accountants in connection with such disposition, in each case as is customary for similar “due diligence” examinations; provided, however, that: 
  
 (i) such persons shall, at the Company’s request, first
agree in writing with the Company that any information that is reasonably and in good faith designated by the Company in writing as confidential at the time of delivery of such information shall be kept confidential by such persons and shall be used
solely for the purposes of exercising rights under this Agreement, unless (A) disclosure of such information is required by court or administrative order or is necessary to respond to inquiries of governmental or regulatory authorities,
(B) disclosure of such information is required by law (including any disclosure requirements pursuant to federal securities laws in connection with the filing of any Shelf Registration Statement or the use of any Prospectus referred to in this
Agreement) or necessary to defend or prosecute a claim brought against or by any such persons (e.g., to establish a “due diligence” defense), (C) such information becomes generally available to the public other than as a result
of a disclosure or failure to safeguard by any such person or (D) such information becomes available to any such person from a source other than the Company and such source is not bound by a confidentiality agreement or is not otherwise under a
duty of trust to the Company, provided that such person shall promptly give notice to the Company of any disclosure described in clause (A) or (B) above; and 
  
 (ii) the foregoing inspection and information gathering shall, to the greatest extent possible, be
coordinated on behalf of all the Notice Holders and the other parties entitled thereto by the counsel, referred to in Section 5, for the Holders in connection with Shelf Registration Statements. 
  
 (k) Comply with all applicable rules and regulations of the
SEC; and make generally available to its securityholders earnings statements (which need not be audited) satisfying the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any similar rule promulgated under the
Securities Act), which statements shall cover a period of twelve (12) months commencing on the first day of the first fiscal quarter of the Company commencing after the effective date of each Shelf Registration Statement (within the meaning of
Rule 158(c) under the Securities Act), and which statements shall be so made generally available to the Company’s securityholders no later than forty (40) days after the end of the applicable twelve (12) month period if such period
ends on or after December 15, 2004 and before December 15, 2006 (or thirty five (35) days after the end of the applicable twelve (12) month period if such period ends on or after December 15, 2006) (or, if such earnings
statement is filed with the SEC on Form 10-K under the Exchange Act, (i) seventy five (75) days after the end of the applicable twelve (12) month period if such period ends before December 15, 2005 or (ii) sixty
(60) days after the end 

  

 - 17 - 

 
of the applicable twelve (12) month period if such period ends on or after December 15, 2005); provided, however, that, to the extent
any such earnings statement will be contained in one report, or any combination of reports, on Form 10-K and/or Form 10-Q under the Exchange Act filed by the Company with the SEC and the deadline, under the Exchange Act, for the Company to file,
with the SEC, such report, if such earnings statement is contained in a Form 10-K, or to file, with the SEC, the last of such reports which together constitute such earnings statement, if such earnings statement is contained in a combination of
reports, is a date that is later than the applicable foregoing deadline, then such later date shall apply in place of the otherwise applicable foregoing deadline. 
  
 (l) Cooperate with each Notice Holder to facilitate the timely preparation and delivery of certificates
representing Registrable Securities sold pursuant to a Shelf Registration Statement, which certificates shall not bear any restrictive legends, and cause such Registrable Securities to be in such denominations as are permitted by the Indenture and
registered in such names as such Notice Holder may request in writing at least two (2) Business Days prior to any sale of such Registrable Securities. 
  
 (m) Provide a CUSIP number for all Registrable Securities covered by a Shelf Registration Statement not later than the effective date of
the Initial Shelf Registration Statement and provide the Trustee and the transfer agent for the Common Stock with certificates for the Registrable Securities that are in a form eligible for deposit with The Depository Trust Company. 
  
 (n) Cooperate and assist in any filings required to be made
with the National Association of Securities Dealers, Inc. 
  
 (o) Upon the filing of the Initial Shelf Registration Statement, and upon the effectiveness under the Securities Act of the Initial Shelf Registration Statement, announce the same, in each case by release through a
reputable national newswire service. 
  
 (p) Take
all actions and enter into such customary agreements (including, if requested, an underwriting agreement in customary form) as are necessary, or reasonably requested by the Holders of a majority of the Registrable Securities being sold, in order to
expedite or facilitate disposition of such Registrable Securities; and in such connection, whether or not an underwriting agreement is entered into and whether or not the registration is an underwritten registration: 
  
 (i) the Company shall make such representations and
warranties to the Holders of such Registrable Securities and the underwriters, if any, in form, substance and scope as would be customarily made by the Company to underwriters in similar offerings of securities; 
  
 (ii) the Company shall obtain opinions of counsel of the
Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the Managing Underwriters, if any, and to the 

  

 - 18 - 

 
counsel to the Holders of the Registrable Securities being sold) addressed to each selling Holder and the underwriters, if any, covering the matters that
would be customarily covered in opinions requested in sales of securities or underwritten offerings; 
  
 (iii) the Company shall obtain “comfort letters” and updates thereof from the Company’s independent certified public
accountants (and, if necessary, any other independent certified public accountants of any subsidiary of the Company or of any business acquired by the Company for which financial statements are, or are required to be, included in any Shelf
Registration Statement) addressed to the underwriters, if any, and the selling Holders of Registrable Securities (to the extent consistent with Statement on Auditing Standards No. 72 of the American Institute of Certified Public Accounts), such
letters to be in customary form and covering matters of the type that would customarily be covered in “comfort letters” to underwriters in connection with similar underwritten offerings; 
  
 (iv) the Company shall, if an underwriting agreement is
entered into, cause any such underwriting agreement to contain indemnification provisions and procedures substantially equivalent to the indemnification provisions and procedures set forth in Section 6 hereof with respect to the underwriters
and all other parties to be indemnified pursuant to said Section; and 
  
 (v) the Company shall deliver such documents and certificates as may be reasonably requested and as are customarily delivered in similar offerings to the holders of a majority of the Registrable Securities being sold
and to the Managing Underwriters, if any; 
  
 the above to be
done at (x) the effectiveness of any Shelf Registration Statement (and each post-effective amendment thereto) and (y) each closing under any underwriting or similar agreement as and to the extent required thereunder. 
  
 (q) Cause the Indenture to be qualified under the TIA not
later than the effective date of the Initial Shelf Registration Statement; and, in connection therewith, cooperate with the Trustee to effect such changes to the Indenture as may be required for the Indenture to be so qualified in accordance with
the terms of the TIA and execute, and use its best efforts to cause the Trustee to execute, all documents as may be required to effect such changes, and all other forms and documents required to be filed with the SEC to enable the Indenture to be so
qualified in a timely manner. 
  
 (r) Cause the
Underlying Common Stock to be listed on The Nasdaq National Market. 
  
 (s) In the event that any broker-dealer registered under the Exchange Act shall underwrite any Registrable Securities or participate as a member of an underwriting syndicate or selling group or “participate in a
public offering” (within the meaning of the 

  

 - 19 - 

 
Conduct Rules (the “NASD Rules”) of the National Association of Securities Dealers, Inc.) thereof, whether as a Holder of such Registrable
Securities or as an underwriter, a placement or sales agent or a broker or dealer in respect thereof, or otherwise, the Company will assist such broker-dealer in complying with the requirements of such NASD Rules, including, without limitation, by:
(i) if such NASD Rules, including NASD Rule 2720, shall so require, engaging a “qualified independent underwriter” (as defined in NASD Rule 2720) to participate in the preparation of the Shelf Registration Statement relating to such
Registrable Securities, to exercise usual standards of due diligence in respect thereof and, if any portion of the offering contemplated by such Shelf Registration Statement is an underwritten offering or is made through a placement or sales agent,
to recommend the yield or price, as the case may be, of such Registrable Securities; (ii) indemnifying any such qualified independent underwriter to the extent of the indemnification of underwriters provided in Section 6 hereof; and
(iii) providing such information to such broker-dealer as may be required in order for such broker-dealer to comply with the requirements of the NASD Rules. 
  
 4. Holder’s Obligations. Each Holder agrees, by acquisition of the Registrable Securities, that no Holder of
Registrable Securities shall be entitled to sell any of such Registrable Securities pursuant to a Shelf Registration Statement or to receive a Prospectus relating thereto, unless such Holder has furnished the Company with a Notice and Questionnaire
as required pursuant to Section 2(d) hereof (including the information required to be included in such Notice and Questionnaire) and the information set forth in the next sentence. Each Notice Holder agrees promptly to furnish to the Company all
information required to be disclosed in order to make the information previously furnished to the Company by such Notice Holder not misleading and any other information regarding such Notice Holder and the distribution of such Registrable Securities
as the Company may from time to time reasonably request. Any sale of any Registrable Securities by any Holder shall constitute a representation and warranty by such Holder that the information relating to such Holder and its plan of distribution is
as set forth in the Prospectus delivered by such Holder in connection with such disposition, that such Prospectus does not as of the time of such sale contain any untrue statement of a material fact relating to or provided by such Holder or its plan
of distribution and that such Prospectus does not as of the time of such sale omit to state any material fact relating to or provided by such Holder or its plan of distribution necessary in order to make the statements in such Prospectus, in the
light of the circumstances under which they were made, not misleading. 
  
 5. Registration Expenses. The Company shall bear all fees and expenses incurred in connection with the performance by the Company of its obligations under Section 2 and Section 3 of this Agreement whether or not any of the
Shelf Registration Statements are filed or declared effective under the Securities Act. Such fees and expenses (“Registration Expenses”) shall include, without limitation, (i) all registration and filing fees and expenses
(including, without limitation, fees and expenses (x) with respect to filings required to be made with the National Association of Securities Dealers, Inc. and (y) of compliance with federal securities laws and state securities or Blue Sky
laws (including, without limitation, reasonable fees and disbursements of counsel for the Holders in connection with Blue Sky qualifications of the Registrable Securities under the laws of such jurisdictions as the Notice Holders of a majority of

  

 - 20 - 

 
the Registrable Securities being sold pursuant to a Shelf Registration Statement may designate), (ii) all printing expenses (including, without
limitation, expenses of printing certificates for Registrable Securities in a form eligible for deposit with The Depository Trust Company and printing Prospectuses), (iii) all duplication and mailing expenses relating to copies of any Shelf
Registration Statement or Prospectus delivered to any Holders hereunder, (iv) all fees and disbursements of counsel for the Company and the fees and disbursements of one counsel for the Holders in connection with the Shelf Registration
Statement, (v) all fees and disbursements of the Trustee and its counsel and of the registrar and transfer agent for the Common Stock, (vi) the reasonable fees and disbursements, in connection with the review of the Shelf Registration
Statement(s), of Willkie Farr & Gallagher LLP, counsel for the Initial Purchasers, which fees and disbursements shall not exceed an aggregate of twenty thousand dollars ($20,000) during the term of this Agreement and (vii) Securities
Act liability insurance obtained by the Company in its sole discretion. In addition, the Company shall pay the internal expenses of the Company (including, without limitation, all salaries and expenses of officers and employees performing legal or
accounting duties), the expense of any annual audit or quarterly review, the fees and expenses incurred in connection with the listing by the Company of the Registrable Securities on any securities exchange or quotation system on which similar
securities of the Company are then listed and the fees and expenses of any person, including, without limitation, special experts, retained by the Company. 
  
 6. Indemnification, Contribution. 
  
 (a) The Company agrees to indemnify, defend and hold harmless the Initial Purchasers, each Holder, each person (a “Controlling
Person”), if any, who controls the Initial Purchasers or Holder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and the respective officers, directors, partners, employees, representatives
and agents of the Initial Purchasers, the Holders or any Controlling Person (each, an “Indemnified Party”), from and against any loss, damage, expense, liability, claim or any actions in respect thereof (including the reasonable
cost of investigation) which such Indemnified Party may incur or become subject to under the Securities Act, the Exchange Act or otherwise, insofar as such loss, damage, expense, liability, claim or action arises out of or is based upon any untrue
statement or alleged untrue statement of a material fact contained in any Shelf Registration Statement or Prospectus, including any document incorporated by reference therein, or in any amendment or supplement thereto or in any preliminary
prospectus, or arises out of or is based upon any omission or alleged omission to state a material fact required to be stated in any Shelf Registration Statement or in any amendment or supplement thereto or necessary to make the statements therein
not misleading, or arises out of or is based upon any omission or alleged omission to state a material fact necessary in order to make the statements made in any Prospectus or in any amendment or supplement thereto or in any preliminary prospectus,
in the light of the circumstances under which such statements were made, not misleading, and the Company shall reimburse, as incurred, the Indemnified Parties for any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such loss, damage, expense, liability, claim or action in respect thereof; provided, however, that the Company shall not be required to provide any indemnification pursuant to this Section 6(a) in
any such case 

  

 - 21 - 

 
insofar as any such loss, damage, expense, liability, claim or action arises out of or is based upon any untrue statement or omission or alleged untrue
statement or omission of a material fact contained in, or omitted from, and in conformity with information furnished in writing by or on behalf of an Initial Purchaser or a Holder to the Company expressly for use in, any Shelf Registration Statement
or any Prospectus; provided further, however, that this indemnity agreement will be in addition to any liability which the Company may otherwise have to such Indemnified Party. 
  
 (b) Each Holder, severally and not jointly, agrees to
indemnify, defend and hold harmless the Company, its directors, officers, employees and any person who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each, a “Company
Indemnified Party”) from and against any loss, damage, expense, liability, claim or any actions in respect thereof (including the reasonable cost of investigation) which such Company Indemnified Party may incur or become subject to under
the Securities Act, the Exchange Act or otherwise, insofar as such loss, damage, expense, liability, claim or action arises out of or is based upon (A) any untrue statement or alleged untrue statement of a material fact contained in, and in
conformity with information (the “Holder Information”) furnished in writing by or on behalf of such Holder to the Company expressly for use in, any Shelf Registration Statement or Prospectus, or arises out of or is based upon any
omission or alleged omission to state a material fact in connection with such Holder Information required to be stated in any Shelf Registration Statement or Prospectus or necessary to make such Holder Information not misleading, or (B) a sale,
by such Holder pursuant to a Shelf Registration Statement in or with respect to which such Holder is named as a selling security holder, of Registrable Securities during a Suspension Period, provided that the Company shall have theretofore provided
such Holder a Suspension Notice in accordance with Section 3(i), or (C) a public sale of Registrable Securities by such Holder without delivery, if required by the Securities Act, of the most recent applicable Prospectus provided to such
Holder by the Company pursuant to Section 2(c)(i)(C), provided the Company shall have theretofore provided such Holder with copies of such Prospectus in a timely manner so as to permit such delivery; and, subject to the limitation set forth in
the immediately preceding clause, each Holder shall reimburse, as incurred, the Company for any legal or other expenses reasonably incurred by the Company or any such controlling person in connection with investigating or defending any loss, damage,
expense, liability, claim or action in respect thereof. This indemnity agreement will be in addition to any liability which such Holder may otherwise have to the Company or any of its controlling persons. In no event shall the liability of any
selling Holder of Registrable Securities hereunder be greater in amount than the dollar amount of the proceeds received by such Holder upon the sale, pursuant to the Shelf Registration Statement, of the Registrable Securities giving rise to such
indemnification obligation. 
  
 (c) If any
action, suit or proceeding (each, a “Proceeding”) is brought against any person in respect of which indemnity may be sought pursuant to either Section 6(a) or Section 6(b), such person (the “Indemnified
Party”) shall promptly notify the person against whom such indemnity may be sought (the “Indemnifying Party”) in writing of the institution of such Proceeding and the Indemnifying Party shall assume the defense of 

  

 - 22 - 

 
such Proceeding; provided, however, that the omission to so notify such Indemnifying Party shall not relieve such Indemnifying Party from any
liability which it may have to such Indemnified Party or otherwise, unless the Indemnifying Party shall be materially prejudiced as a result of the failure to deliver notice, and then only to the extent of such prejudice. Such Indemnified Party
shall have the right to employ its own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party unless the employment of such counsel shall have been authorized in writing by such
Indemnifying Party in connection with the defense of such Proceeding or such Indemnifying Party shall not have employed counsel to have charge of the defense of such Proceeding within thirty (30) days of the receipt of notice thereof or such
Indemnified Party shall have reasonably concluded upon the written advice of counsel that there may be one or more defenses available to it that are different from, additional to or in conflict with those available to such Indemnifying Party (in
which case such Indemnifying Party shall not have the right to direct that portion of the defense of such Proceeding on behalf of the Indemnified Party, but such Indemnifying Party may employ counsel and participate in the defense thereof but the
fees and expenses of such counsel shall be at the expense of such Indemnifying Party), in any of which events such reasonable fees and expenses shall be borne by such Indemnifying Party and paid as incurred (it being understood, however, that such
Indemnifying Party shall not be liable for the expenses of more than one separate counsel in any one Proceeding or series of related Proceedings together with reasonably necessary local counsel representing the Indemnified Parties who are parties to
such action). An Indemnifying Party shall not be liable for any settlement of such Proceeding effected without the written consent of such Indemnifying Party, but if settled with the written consent of such Indemnifying Party, such Indemnifying
Party agrees to indemnify and hold harmless an Indemnified Party from and against any loss or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an Indemnified Party shall have requested an Indemnifying
Party to reimburse such Indemnified Party for fees and expenses of counsel as contemplated by the second sentence of this paragraph, then such Indemnifying Party agrees that it shall be liable for any settlement of any Proceeding effected without
its written consent if (i) such settlement is entered into more than sixty (60) Business Days after receipt by such Indemnifying Party of the aforesaid request, (ii) such Indemnifying Party shall not have fully reimbursed such
Indemnified Party in accordance with such request and as required by this Agreement prior to the date of such settlement and (iii) such Indemnified Party shall have given such Indemnifying Party at least thirty (30) days’ prior notice
of its intention to settle. No Indemnifying Party shall, without the prior written consent of any Indemnified Party, effect any settlement of any pending or threatened Proceeding in respect of which such Indemnified Party is or could reasonably be
expected have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such
Proceeding and does not include an admission of fault or culpability or a failure to act by or on behalf of such Indemnified Party. 
  
 (d) If the indemnification provided for in this Section 6 is unavailable to an Indemnified Party under Section 6(a) or
Section 6(b), or insufficient to hold such 

  

 - 23 - 

 
Indemnified Party harmless, in respect of any losses, damages, expenses, liabilities, claims or actions referred to therein, then each applicable
Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such losses, damages, expenses, liabilities, claims or actions (i) in such proportion as
is appropriate to reflect the relative benefits received by the Company, on the one hand, and by the Holders or the Initial Purchasers, on the other hand, from the offering of the Registrable Securities or (ii) if the allocation provided by
clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and of the
Holders or the Initial Purchasers, on the other hand, in connection with the statements or omissions which resulted in such losses, damages, expenses, liabilities, claims or actions, as well as any other relevant equitable considerations. The
relative fault of the Company, on the one hand, and of the Holders or the Initial Purchasers, on the other hand, shall be determined by reference to, among other things, whether the untrue statement or alleged untrue statement of a material fact or
omission or alleged omission relates to information supplied by the Company or by the Holders or the Initial Purchasers and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission. The amount paid or payable by a party as a result of the losses, damages, expenses, liabilities, claims and actions referred to above shall be deemed to include any reasonable legal or other fees or expenses reasonably incurred by such
party in connection with investigating or defending any Proceeding. 
  
 (e) The Company, the Holders and the Initial Purchasers agree that it would not be just and equitable if contribution pursuant to this Section 6 were determined by pro rata allocation or by any other method of
allocation which does not take account of the equitable considerations referred to in Section 6(d) above. Notwithstanding the provisions of this Section 6, no Holder shall be required to contribute any amount in excess of the amount by
which the total price at which the Registrable Securities giving rise to such contribution obligation and sold by such Holder were offered to the public exceeds the amount of any damages which it has otherwise been required to pay by reason of such
untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. The Holders’ respective obligations to contribute pursuant to this Section 6 are several in proportion to the respective amount of Registrable Securities they have sold pursuant to a Shelf
Registration Statement, and not joint. The remedies provided for in this Section 6 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity. 
  
 (f) The indemnity and contribution provisions contained in
this Section 6 shall remain operative and in full force and effect regardless of (i) any termination of this Agreement, (ii) any investigation made by or on behalf of any Holder or the Initial Purchasers or any person controlling any
Holder or the Initial Purchasers, or the Company, or the Company’s officers or directors or any person controlling the Company and (iii) the sale of any Registrable Security by any Holder. 
  

 - 24 - 

 7. Information Requirements. 
  
 (a) The Company covenants that, if at any time before the end of the Effectiveness Period it is not subject
to the reporting requirements of the Exchange Act, it will cooperate with any Holder of Registrable Securities and take such further action as any Holder of Registrable Securities may reasonably request in writing (including, without limitation,
making such representations as any such Holder may reasonably request), all to the extent required from time to time to enable such Holder to sell Registrable Securities without registration under the Securities Act within the limitations of the
exemptions provided by Rule 144, Rule 144A, Regulation S and Regulation D under the Securities Act and customarily taken in connection with sales pursuant to such exemptions. Upon the written request of any Holder, the Company shall deliver to such
Holder a written statement as to whether the Company has complied with the reporting requirements of the Exchange Act, unless such a statement has been included in the Company’s most recent report filed with the SEC pursuant to Section 13
or Section 15(d) of Exchange Act. Notwithstanding the foregoing, nothing in this Section 7 shall be deemed to require the Company to register any of its securities (other than the Common Stock) under any section of the Exchange Act.

  
 (b) The Company shall file the reports
required to be filed by it under the Exchange Act and shall comply with all other requirements set forth in the instructions to Form S-3 in order to allow the Company to be eligible to file registration statements on Form S-3. 
  
 8. Underwritten Registrations. 
  
 (a) If any of the Registrable Securities covered by the
Shelf Registration Statement are to be offered and sold in an underwritten offering, the investment banker or investment bankers and manager or managers that will administer the offering (“Managing Underwriters”) shall be selected
by the holders of a majority of such Registrable Securities to be included in such offering, which investment banker or investment bankers shall be reasonably acceptable to the Company. 
  
 (b) No person may participate in any underwritten registration hereunder unless such person (i) agrees
to sell such person’s Registrable Securities on the basis reasonably provided in any underwriting arrangements approved by the persons entitled hereunder to approve such arrangements and (ii) completes and executes all questionnaires,
powers of attorney, indemnities, underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements. 
  
 9. Miscellaneous. 
  
 (a) Remedies. The Company acknowledges and agrees that any failure by the Company to comply with its obligations under this
Agreement may result in material 

  

 - 25 - 

 
irreparable injury to the Initial Purchasers and the Holders for which there is no adequate remedy at law, that it will not be possible to measure damages
for such injuries precisely and that, in the event of any such failure, the Initial Purchasers or Holder may obtain such relief as may be required to specifically enforce the Company’s obligations under this Agreement. The Company further
agrees to waive the defense in any action for specific performance that a remedy at law would be adequate. Notwithstanding the foregoing two sentences, this Section 9(a) shall not apply to the subject matter referred to in and contemplated by
Section 2(d). 
  
 (b) No Conflicting
Agreements. The Company is not, as of the date hereof, a party to, nor shall it, on or after the date of this Agreement, enter into, any agreement with respect to the Company’s securities that conflicts with the rights granted to the
Holders in this Agreement. The Company represents and warrants that the rights granted to the Holders hereunder do not in any way conflict with the rights granted to the holders of the Company’s securities under any other agreements. The
Company will not take any action with respect to the Registrable Securities which would adversely affect the ability of any of the Holders to include such Registrable Securities in a registration undertaken pursuant to this Agreement. The Company
represents and covenants that it has not granted, and shall not grant, to any of its security holders (other than the Holders in such capacity) the right to include any of the Company’s securities in any Shelf Registration Statement filed
pursuant to this Agreement. 
  
 (c) Amendments
and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the Company has
obtained the written consent of Holders of a majority of outstanding Registrable Securities; provided, however, that, no consent is necessary from any of the Holders in the event that this Agreement is amended, modified or supplemented
for the purpose of curing any ambiguity, defect or inconsistency that does not adversely affect the rights of any Holders. Notwithstanding the foregoing, a waiver or consent taking effect either prospectively or retroactively to depart from the
provisions hereof with respect to a matter that relates exclusively to the rights of Holders of Registrable Securities whose securities are being sold pursuant to a Shelf Registration Statement and that does not directly or indirectly affect the
rights of other Holders of Registrable Securities may be given by Holders of at least a majority of the Registrable Securities being sold by such Holders pursuant to such Shelf Registration Statement; provided, however, that the
provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of the immediately preceding sentence. Each Holder of Registrable Securities outstanding at the time of any such amendment,
modification, supplement, waiver or consent or thereafter shall be bound by any such amendment, modification, supplement, waiver or consent effected pursuant to this Section 9(c), whether or not any notice, writing or marking indicating such
amendment, modification, supplement, waiver or consent appears on the Registrable Securities or is delivered to such Holder. 
  
 (d) Notices. All notices and other communications provided for or permitted 

  

 - 26 - 

 
hereunder shall be made in writing by hand delivery, by telecopier, by courier guaranteeing overnight delivery or by first-class mail, return receipt
requested, and shall be deemed given (A) when made, if made by hand delivery, (B) upon confirmation, if made by telecopier, (C) one (1) Business Day after being deposited with such courier, if made by overnight courier or
(D) on the date indicated on the notice of receipt, if made by first-class mail, to the parties as follows: 
  
 (i) if to a Holder, at the most current address given by such Holder to the Company in a Notice and Questionnaire or any amendment
thereto; 
  

	 	(ii)	if to the Company, to: 

  
 The TriZetto Group, Inc. 
 567 Nicolas Drive, Suite 360 
 Newport Beach, CA 92661 
 Attention: Chief Financial Officer 
 Telecopy No.: (949) 219-2199 
  

	 	(iii)	if to the Initial Purchasers, to: 

  
 UBS Securities LLC 
 299 Park Avenue 
 New York, New York 10171 
 Attention: Syndicate Department 
 Telecopy No.: (212) 713-1205 
  
 with a copy to (for informational purposes only): 
  
 UBS Securities LLC 
 299 Park Avenue 
 New York, New York 10171 
 Attention: Legal Department 
 Telecopy No.: (212) 821-4042 
  
 and 
  
 UBS
Securities LLC 
 677 Washington Boulevard 
 Stamford, Connecticut 06901 
 Attention: Syndicate Department 
 Telecopy No.: (203) 719-0683 
  
 or to such other address as such person may have furnished to the other
persons identified in this Section 9(d) in writing in accordance herewith. 
  
 (e) Majority of Registrable Securities. For purposes of determining what 

  

 - 27 - 

 
constitutes holders of a majority of Registrable Securities, as referred to in this Agreement, a majority shall constitute a majority in aggregate principal
amount of Registrable Securities, treating each relevant holder of shares of Underlying Common Stock as a holder of the aggregate principal amount of Notes in respect of which such Common Stock was issued. 
  
 (f) Approval of Holders. Whenever the consent or
approval of Holders of a specified percentage of Registrable Securities is required hereunder, Registrable Securities held by the Company or its “affiliates” (as such term is defined in Rule 405 under the Securities Act) (other than the
Initial Purchasers or subsequent Holders of Registrable Securities, if the Initial Purchasers or such subsequent Holders are deemed to be such affiliates solely by reason of their holdings of such Registrable Securities) shall not be counted in
determining whether such consent or approval was given by the Holders of such required percentage. 
  
 (g) Third Party Beneficiaries. The Holders shall be third party beneficiaries to the agreements made hereunder between the Company,
on the one hand, and the Initial Purchasers, on the other hand, and shall have the right to enforce such agreements directly to the extent they may deem such enforcement necessary or advisable to protect their rights or the rights of Holders
hereunder. The Trustee shall be entitled to the rights granted to it pursuant to this Agreement. 
  
 (h) Successors and Assigns. Any person who purchases any Covered Security from an Initial Purchaser or from any Holder shall be
deemed, for purposes of this Agreement, to be an assignee of such Initial Purchaser or such Holder, as the case may be. This Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of each of the parties
hereto and shall inure to the benefit of and be binding upon each Holder of any Covered Security. 
  
 (i) Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts,
each of which when so executed shall be deemed to be original and all of which taken together shall constitute one and the same agreement. 
  
 (j) Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect
the meaning hereof. 
  
 (k) Governing Law.
THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF. 
  
 (l) Severability. If any term, provision, covenant or restriction of this Agreement is held to be
invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, and the parties

  

 - 28 - 

 
hereto shall use their best efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such
term, provision, covenant or restriction, it being intended that all of the rights and privileges of the parties shall be enforceable to the fullest extent permitted by law. 
  
 (m) Entire Agreement. This Agreement is intended by the parties hereto as a final expression of their
agreement and is intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein and the registration rights granted by the Company with respect to the
Registrable Securities. Except as provided in the Purchase Agreement, there are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein, with respect to the registration rights granted by the Company
with respect to the Registrable Securities. This Agreement supersedes all prior agreements and undertakings among the parties with respect to such registration rights. No party hereto shall have any rights, duties or obligations other than those
specifically set forth in this Agreement. 
  
 (n)
Termination. This Agreement and the obligations of the parties hereunder shall terminate upon the end of the Effectiveness Period, except for any liabilities or obligations under Section 4, Section 5 or Section 6 hereof and the
obligations to make payments of and provide for additional interest under Section 2(d) hereof to the extent such additional interest accrues prior to the end of the Effectiveness Period and to the extent any overdue additional interest accrues
in accordance with the last paragraph of such Section 2(d), each of which shall remain in effect in accordance with its terms. 
  
 (o) Submission to Jurisdiction. Except as set forth below, no claim, counterclaim or dispute of any kind or nature
whatsoever arising out of or in any way relating to this Agreement (“Claim”) may be commenced, prosecuted or continued in any court other than the courts of the State of New York located in the City and County of New York or in the
United States District Court for the Southern District of New York, which courts shall have jurisdiction over the adjudication of such matters, and the Company hereby consents to the jurisdiction of such courts and personal service with respect
thereto. The Company hereby consents to personal jurisdiction, service and venue in any court in which any Claim arising out of or in any way relating to this Agreement is brought by any third party against any Initial Purchaser. THE COMPANY HEREBY
WAIVES ALL RIGHTS TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED UPON CONTRACT, TORT OR OTHERWISE) IN ANY WAY ARISING OUT OF OR RELATING TO THIS AGREEMENT. The Company agrees that a final judgment in any such Proceeding brought in any such court
shall be conclusive and binding upon the Company and may be enforced in any other courts in the jurisdiction of which the Company is or may be subject, by suit upon such judgment. 
  
 [The Remainder of This Page Intentionally Left Blank; Signature Page Follows] 
  

 - 29 - 

 In Witness Whereof, the parties have executed this Agreement as of the date first written above.

  

			
	 Very truly yours,

	
	THE TRIZETTO GROUP, INC.
		
	By:	 	  

	Name:	 	 
	Title:	 	 

 Accepted and agreed to as of the date first above written, on behalf of itself and the
other several Initial Purchasers: 
  

			
	 UBS Securities LLC

		
	By:	 	  

	Name:	 	 
	Title:	 	 
		
	By:	 	  

	Name:	 	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}]]